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Abstract: Variations in human papillomavirus (HPV) vaccine uptake rates across the nation are 
not understood, especially among college aged students. Most sexually active women and men 
will become infected with HPV unless they receive HPV vaccination (CDC, 2019; President’s 
Cancer Panel, 2018). This study used both quantitative and qualitative methods to examine 254 
male and female undergraduate college students’ vaccine status, knowledge, and perceived risk 
of contracting HPV. Further, this study captured student narratives related to how health care 
providers influence their vaccine decision and what types of information have been shared. 
Females received a provider recommendation for vaccine and were fully vaccinated more often 
than male students. However, a group of students were unsure of their vaccine status, which was 
related to low knowledge and misperceptions of risk. Some students were unable to identify risk 
factors related to contracting HPV and many did not view the vaccine applicable to themselves. 
Regardless of vaccine status, students in this study had low knowledge and held misconceptions 
about the vaccine. Many students reported the health care provider had not been a source of 
information, had not been an influence on their vaccine decision, and had not recommended the 
vaccine. There is evidence to support health care providers should introduce or return to previous 
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The Centers for Disease Control and Prevention (CDC) and the President’s Cancer Panel 
have identified improving uptake of human papillomavirus (HPV) vaccines as a public health 
priority (National Foundation for Infectious Diseases, 2014). HPV is the most common sexually 
transmitted infection in the United States (CDC, 2019).  Approximately 80 million Americans 
are infected with HPV and about 14 million people become newly infected each year (CDC, 
2019). Health complications deriving from HPV infection most commonly include genital warts 
and cancers of the cervix but can develop in other locations such as the vulva, vagina, penis, or 
anus. HPV can also cause cancers in the back of the throat, including the base of the tongue and 
tonsils (CDC, 2019). Since 2006, when HPV vaccines were first developed, there have been 
changes in the range of protection they offer and the dosing regimen [Kaiser Family Foundation 
(KFF), 2018].Vaccine uptake rates are slightly improving, the percentage of adolescents who 
started the HPV vaccine series increased by five percentage points each year from 2013-2017 
(CDC, 2018) and 66% of adolescents ages 13-17 years received the first dose to start the vaccine 
series. 
However, only roughly half (49%) of adolescents are up to date on the HPV vaccine 
(CDC, 2018) and incomplete series remain a problem. There exists a significant gap in vaccine 
coverage of HPV among college-aged students (Rohde et al., 2018). National vaccination 
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coverage results indicate that many young adult women and men who could benefit from 
the vaccine have not received it (Marchand, Glenn, & Bastani, 2012).  
Most sexually active women and men will become infected with HPV unless they receive 
HPV vaccination (CDC, 2019; President’s Cancer Panel, 2018). Therefore, the CDC and the 
Advisory Committee on Immunization Practices (ACIP) are strongly encouraging vaccination. 
Advancement in HPV immunology saw the December of 2014 Food and Drug Administration 
(FDA) approval of the HPV Gardasil®-9 VIS. However, the CDC has cautioned without higher 
rates of uptake, “…it might be decades before an impact of vaccination is observed (CDC, 
2014).”  Since January 2017, only Gardasil®-9 has been available in the United States.  ACIP   
recommends vaccination for females through age 26 and for males through age 21 who were not 
adequately vaccinated previously (President’s Cancer Panel, 2018). 
Variations in HPV vaccine uptake rates across the nation are not understood, especially 
among older adolescents and college aged students. Misinformation regarding HPV as well as a 
lack of HPV knowledge affects attitudes and vaccine uptake (McCutcheon & Schaar, 2017).  
There also are differences in by race/ethnicity, socioeconomic status, and insurance status 
(President’s Cancer Panel, 2018). Rates are particularly low in rural areas, despite high uptake of 
other adolescent vaccines; over half of adolescents in urban areas are up to date on their HPV 
vaccination compared with only 42% in rural areas. There are lower odds of receiving the HPV 
vaccine reported among students attending colleges and universities outside of the northeastern 
United States (Lindley et al., 2013).  
College students’ sexual behaviors and psychosocial factors (Ratanasiripong, 2012) put 
them at risk for HPV exposure and infection. However, being sexually active may not be 
influencing the college student decision to get vaccinated to prevent HPV infection (Vasquez, et 
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al., 2016). The 2018 National College Health Assessment (NCHA) had 88,178 student 
respondents from 140 schools, and 80% of the respondents were between 18 and 24 years old. 
Over 60% of both males and females had one or more sexual partners (oral sex, vaginal or anal 
intercourse) within the last 12 months (males 65.3% and females 68.6%). Half of the women 
(50.4%) had vaginal intercourse within the last 30 days. Among those women, 42.4% of them 
either never or rarely used a condom or other protective barriers (NCHA, 2018). In this study, 
only 56.1% reported receiving vaccination against HPV (NCHA, 2018).  
College-aged males are at high risk for contracting HPV due to a lack of HPV knowledge 
and low vaccination rates (McCutcheon & Schaar, 2017). College students are a high-risk 
population for sexually transmitted infections due to increased rates of sexual activity, multiple 
sexual partners, and unprotected sexual encounters (American College Health Association 
(ACHA), 2018). College students are of prime importance since they comprise the age groups 
for females at highest risk for HPV; according to national data, 20 to 24 year old females had the 
highest prevalence of genital HPV (Thompson et al, 2016).  Sexual behavioral patterns of college 
students demonstrate that both males and females are equal contributors in HPV transmission 
(Cunningham-Erves & Talbott, 2015). Research regarding college students’ vaccination uptake 
and HPV knowledge regarding this vaccine is beginning to appear in the literature. However, the 
complexities of decision making and what led to vaccination are not completely understood. The 
relationship between HPV knowledge and vaccine uptake has been found to be inconsistent 
(Ratanasiripong, 2012).  While individuals may report knowledge, they may mistake being 
aware of the vaccine for a true understanding of their personal risk and need for vaccination. 
Risk may be deemed as a negative or undesirable outcome, and as such, is synonymous with the 
terms danger or hazard, or it may be viewed as a category of understanding (Wyndham-West, 
4 
 
2016). Commonly found in the literature, a health care provider recommendation is cited as 
essential to adolescent vaccine uptake. However, the precise communications between provider 
and college students that lead to vaccine decisions are not strongly documented. Assuming 
college students have more autonomy in their health behaviors; other factors that drive college 
students’ decision making still need inquiry.   
Vaccine Completion Rates in Adolescent Females 
 Data has been collected on vaccine initiation as well as completion in age categories 
since the first HPV vaccines became available.  Current recommendations are for routine 
vaccination at age 11 or 12 (Morbidity and Mortality Weekly Report (MMWR), 2015).  
However, uptake rates are notably lower than the other routine childhood vaccines. The U.S. 
Department of Health and Human Services (2016) reported in 2008 that only 16.6 percent of 
females aged 13 to15 years old had received at least three doses of HPV vaccine.  On average for 
all states in the United States in 2010, only 32% of eligible girls and women had received all 
three doses of the vaccines. HPV vaccination coverage among adolescent girls 13 to 17 years old 
failed to increase from 2011 to 2012 (CDC, 2013; CDC, 2015) and increased only modestly in 
2013, and an additional 3.3 percentage points in 2014 (CDC, 2015). Based on results of the 2011 
National Immunization Survey-Teen, only 53.0% of girls 13 to 17 years old received one dose of 
HPV vaccine, and only 34.8% received all three doses of the HPV vaccine series (CDC, 2013).  
Currently, The Healthy People 2020 goal of 80% uptake of all three doses of the HPV 
vaccine among girls 13-15 years old is far from being met (President’s Cancer Panel, 2018). In 
2018, the percentage of adolescents up to date with the HPV vaccine series increased from 
48.6% to 51.1%; the increase in HPV vaccination coverage was attributable to increases among 
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males only (increase of 4.4 percentage points in males who were up to date versus 0.6 in 
females) (Walker et al., 2019).  
ACIP also recommends vaccination for all females aged 13 through 26 years and males 
aged 13 to 21 years not vaccinated previously (CDC, 2015; Petrosky et al., 2015).  For college-
aged students, a ‘catch up’ vaccine may be recommended; most college-aged students were 
vaccine eligible as adolescents. Noting, college-aged students today were vaccine eligible to 
receive one of three FDA approved vaccines in their pre-teen years. However, only 34.5 % of 
women age 19–26 years old report receiving at least one dose of the HPV vaccine (Wilson et al., 
2016). Women ages 18–26 are lagging behind those 11–17 years old (Marchand, Glenn, & 
Bastani, 2012). Understanding and increasing vaccine uptake for 18–26-year-olds is particularly 
important, as risk for acquiring HPV increases rapidly for many women during these years 
(Marchand, Glenn, & Bastani, 2012). 
The uptake data suggests that the HPV vaccine series is somehow presented differently 
by health professionals than other childhood vaccines that are more commonly received. Among 
unvaccinated girls, 84% had a health-care encounter in which they received a vaccine but not 
HPV vaccine (MMWR, 2014). If HPV vaccine was administered at health-care encounters when 
other recommended vaccines were administered, vaccination coverage could be as high as 92.6% 
(MMWR, 2014).  
Vaccine Completion Rates in Adolescent Males 
A disparity exists in HPV vaccination uptake in males, and research regarding young 
men’s HPV vaccination behavior is sparse (Lee et al., 2018). When the President’s Cancer 
Panel’s 2012-2013 report was released, vaccination coverage among adolescent boys lagged far 
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behind that of girls, at least in part because the ACIP recommendation for boys was not issued 
until 2011(President’s Cancer Panel, 2018).  In 2012, only 20.8% of boys ages 13-17 had 
received at least one dose, and only 6.8% had completed the series. Immunization rates for boys 
remain lower than for girls (44% vs. 53% HPV up to date in 2017) (KFF, 2018); but some 
progress has been observed.     
Since HPV vaccines were first introduced in the U.S. in 2006, there have been changes in 
the range of protection they offer and the dosing regimen. Furthermore, the vaccines were 
originally recommended only for girls and young women and were subsequently broadened to 
include boys and young men (KFF, 2018). There may be a widespread mindset that Gardasil, the 
HPV vaccine, is only for females. Consider too, the incidence and prevalence of HPV in the 
male population is unknown due to the asymptomatic nature of the virus in addition to limited 
screening procedures available to males (McCutcheon & Schaar, 2017). These and other factors 
have resulted in a population that does not see itself at risk for HPV and is unaware of its role in 
the transmission of HPV or potential role in the prevention of HPV (Pitts & Stanley, 2017).  
The low vaccination rate among males is particularly troublesome because of their status 
as primary vectors for the transmission of HPV (Reiter, Pendergraft, & Brewer, 2010). This 
means that by the time males enter college, a period marked by increased sexual activity and risk 
taking (Arnett, 2000), a significant proportion of them are unvaccinated and at risk for the 
acquisition and transmission of HPV (Pitts & Stanley, 2017). In the United States, approximately 
51.1% of males carry multiple strains of HPV (McCutcheon & Schaar, 2017). However, there 
are widespread perceptions of low HPV severity and/or susceptibility among college males, and 
a generally dismissive attitude toward HPV as a health concern (Fontenot et al., 2014; Pitts & 
Stanley, 2017).  
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In a study of males aged 18-26 (n = 2516), the percent of HPV vaccine series completion 
showed a decreasing trend with increasing year in undergraduate studies (Lee et al., 2018). In a 
study of 735 sexually active male college students aged 18-25, the vast majority (74%) of 
participants had not obtained the vaccine (Fontenot et al., 2014). For every year older, on the 
continuous range of 18 to 25 years, there was a 24% lower odd of having obtained the HPV 
vaccine (Fontenot et al., 2014). 
Purpose of Study 
The purpose of this study was to determine female and male university students’ current 
vaccination status, knowledge about HPV, and how conversations with health care providers 
influenced vaccine decision making. For all participants, a study aim was to see if HPV related 
knowledge is related to vaccine status. For vaccinated and un-vaccinated participants, this study 
sought to understand themes in message presentation conveyed by provider and how they acted as 
cues to action or otherwise influenced students’ decision making. The study also sought to capture 
any differences in HPV vaccine uptake, HPV knowledge, and if different provider messages were 
received by gender. 
Guiding Research Questions 
Research Question 1 
What is the HPV vaccination status of female and male college students? 
Hypothesis 1:  
Female students will have higher HPV vaccine initiation and completion than male students.  
Research Question 2 




Female students will have higher HPV and HPV vaccine knowledge scores than male students.  
Research Question 3 
Do HPV knowledge scores vary by vaccination status? 
There will be differences between HPV knowledge scores and vaccine status.  
Research Question 4  
What are students’ personal perceived risk of HPV infection? 
Hypothesis 4: 
Vaccine initiators and completers will have lower perceived risk than non-vaccinated students.  
Research Question 5 
What information regarding HPV and HPV vaccination was communicated by health care 
providers to college students?  
Hypothesis 5: 
Due to exploratory nature of this question, there is no hypothesis.  
Significance of the Study 
College-aged populations have the highest rates of HPV infection, fall within the 
recommended age range for HPV vaccination and are the next generation of parents for whom 
HPV vaccine decision-making will rely (Bynum et al., 2011). Regarding vaccination knowledge 
and uptake, public health efforts have surprisingly neglected college-aged women in this 
prevention effort, focusing largely on preadolescent girls (Hopfer & Clippard, 2017). 
Understanding psychological determinants of vaccination behaviors is critical to building 
effective communication aimed at enhancing vaccine uptake (Kim & Nan, 2015). Surprisingly, 
enhancing HPV-related knowledge does not necessarily result in increased vaccine uptake 
(Fernandez et al., 2015).  
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The literature has yet to firmly identify what specifically in the provider and patient 
encounter results in vaccination completion. There is no protocol for providers to follow 
regarding HPV vaccine communication according to the CDC or Advisory Committee on 
Immunization Practices (ACIP). Yet, both agencies are insisting that vaccine uptake rates can be 
improved through provider recommendations. The literature does not pinpoint vaccine uptake to 
a particular behavioral theory. However, this study aims to further understand themes within 
provider communication that led to student vaccine decision making.   
Oklahoma has a low percentage of HPV vaccine uptake compared to the rest of the 
United States (Oklahoma Breast and Cervical Cancer Prevention and Treatment Advisory 
Committee (BCCPT), 2018). Screening for cervical cancer is low, and incidence and mortality 
rates of cervical cancer continue to be high. In Oklahoma, only 45.6% of females aged 13 to 17 
are up to date on all the recommended doses (KFF, 2018). Of note, there has not been an HPV 
knowledge and vaccine uptake study with the intended participants of college students in this 














 Research surrounding college student attitudes and knowledge about HPV and HPV 
vaccine uptake has been guided by an evolving timeline. This timeline reflects attempts at 
understanding and explaining a spectrum of attitudes and acceptance throughout the course of 
development of the three FDA approved vaccines and subsequent changing medical protocols for 
administration. Notably, the original vaccines were for females only, and only in 2009 included 
recommendations for males. Therefore, it is important to consider that research since 2006 has 
been shaped by these emerging developments. Gender differences in uptake rates, attitudes, and 
knowledge of HPV and vaccines understandably may also be shaped by this timeline.  
HPV and Cervical Disease Etiology 
 Human papilloma viruses (HPVs) are a group of more than 200 related viruses, 40 of 
which are contracted sexually, through intimate skin-to skin contact (CDC, 2015). Sexually 
transmitted HPV types fall into two risk categories of risk (low and high); both have negative 
health outcomes for those infected (National Institutes of Health (NIH), 2015). Because the 
infection is so common, most people get HPV infections shortly after becoming sexually active 
for the first time (NIH, 2015). Further, it is possible to become infected with more than one type 
of HPV (CDC, 2015).
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Most people with HPV do not know they are infected (CDC, 2014). Transmission can 
easily occur without one’s knowledge, given most people with HPV never develop symptoms or 
health problems (CDC, 2015). HPV infection often is present without signs or symptoms, and 
there is no test to find out a person’s “HPV status” (CDC, 2014). The CDC estimates that more 
than 90% of sexually active men and 80% of women will be infected with at least one type of 
HPV at some point in their lives (NIH, 2015). 
Persistent oncogenic HPV infection is the strongest risk factor for development of 
cervical pre-cancerous lesions and cancers (CDC, 2010). Epidemiologic case series have shown 
that nearly 100% of cervical cancer cases test positive for HPV (Saslow, Solomon, Lawson, et 
al., 2012). It is estimated that half of the women diagnosed with cervical cancer have never been 
screened for cervical cancer, and an additional 10% have not been screened in the previous 5 
years (CDC, 2012).  
Forty HPV types infect the genital area (Markowitz, et al., 2014). Most notably, HPV 
types 16 and 18 cause 70% of cervical cancers. Type 16 also causes the majority of other cancers 
attributable to HPV. Ninety percent of anogenital warts (condylomata) and most cases of 
recurrent respiratory papillomatosis are caused by Type 6 or 11 (Petrosky, Bocchini, Hariri, et 
al., 2015).  
Prevention efforts in the form of pre-exposure vaccination to young girls aged 11 to 13 
has the potential to drastically reduce the burden of disease experienced within the population. 
Adolescent cervical cancer prevention programs should focus on universal HPV vaccination, 
which is safe, highly efficacious, and, when used in adolescents before they become sexually 
active, highly effective, and cost-effective (Saslow, et al., 2012). In clinical trials, each of the 
vaccines provided close to 100% protection against precancers and for Gardasil ® and Gardasil 
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9®, genital warts (CDC, 2015). Research also shows the vaccines are providing long lasting 
protection from HPV infection and associated disease (CDC, 2015). After completion of the 
vaccine series, there is no indication that booster immunizations will be needed (CDC, 2015). 
However, for all ages, HPV vaccine uptake in the U.S. remains lower than the Healthy People 
2020 goal of 80% coverage (CDC, 2014). In recent years, approximately half of new infections 
occurred among persons aged 15 to 24 (Markowitz, Dunne, Saraiya, et al., 2014). ACIP 
recommends female adolescents receive three doses of HPV vaccine by age 13 to 15. ACIP is a 
federal advisory committee to provide expert advice and guidance to the Director of the CDC on 
use of vaccines; and attempts to align with recommendations made by the American Academy of 
Pediatrics (AAP), the American Academy of Family Physicians (AAFP), and the American 
College of Obstetricians and Gynecologists (ACOG) (Petrosky, et al., 2015).  
Questions Shaping the Literature Review  
(1) What is college students’ knowledge level of HPV and HPV vaccines? (2) How is 
knowledge related to vaccine uptake? (3) Do college students perceive seriousness and severity 
of HPV infections? (4) Do college students believe they are at risk for HPV infection? (5) What 
is the role of provider communication and HPV knowledge and vaccine recommendations?  
 First, it is necessary to generally overview the development of the vaccine and its 
intended recipients. The literature review’s primary areas of focus will include college student 
vaccine status and what related knowledge and attitudes towards HPV are in the literature.  It is 
important to review what gender differences exist given the timeline of vaccine development and 
protocol changes that first applied to females only, then males. This is valuable as there is 
evident gap in vaccine uptake by gender. It is important to understand the documented role of 
provider influence in communicating HPV knowledge and vaccine recommendations.  
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Vaccine History of Development, Indications, and Intended Recipients 
 Historically, the first HPV vaccines were bivalent vaccine (Cervarix) containing HPV 
types 16 and 18. A quadrivalent vaccine (Types 6, 11, 16, and 18) developed by Merck and 
Company, Inc. and was FDA approved under the tradename Gardasil on June 8, 2006. At that 
time, Gardasil was indicated for vaccination in females and subsequently approved for use in 
males on October 16, 2009.  
Merck and Company, Inc. received FDA approval for Gardasil 9 on December 10, 2014. 
It is now the only HPV vaccine used in the USA. This new vaccine has covers nine HPV types, 
five more HPV types (31, 33, 45, 52, and 58) than the original Gardasil (previously approved by 
the FDA, HPV types 6, 11, 16, and 18). Gardasil 9 has the potential to prevent approximately 90 
percent of cervical, vulvar, vaginal, and anal cancers (U.S. Department of Health and Human 
Services, 2014). ACIP updated its HPV vaccine recommendation guidelines in March of 2015 to 
include this new vaccine.  
The manufacturer of Gardasil 9, Merck & Co., Inc. provides this information: It was 
determined to be 97 percent effective in preventing cervical, vulvar, and vaginal cancers caused 
by the five additional HPV types (31, 33, 45, 52, and 58). Gardasil 9 is indicated in girls and 
women, 9 through 26 years of age for prevention of the following:  
• Cervical, vulvar, vaginal, and anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, 
and 58.  
• Genital warts (condyloma acuminata) caused by HPV types 6 and 11.  
• Precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 
58. (USDA Jan. 9, 2015).  
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Ideally, vaccination prior to any sexual activity is best practice; thus the target intended 
age of recipients has been late childhood, early adolescence. Medical science allows for rather 
simplistic reasoning: the earlier the initiation of vaccine, the better opportunity to protect against 
HPV infection. Historically, the ideal recipient of the vaccine has been young girls and 
adolescent females. As of October 2016, CDC recommends 11 to 12 year olds get two doses of 
HPV vaccine (National Foundation for Infectious Diseases (NFID), 2019). However, the vaccine 
can be given as early as age 9.  ACIP also recommends vaccination for all females aged 13 
through 26 years and males aged 13 to 21 years not vaccinated previously (CDC, 2015; NFID, 
2019; Petrosky, Bocchini, Hariri, et al., 2015).  For those who did not receive the vaccine when 
they were younger in accordance with the recommended schedule, females can receive it through 
age 26 and males through age 21 (NFID, 2019).  
HPV Presence in College Student Population 
College students suffer disproportionately from HPV (Yang & Pittman, 2017). Between 
2000 and 2015, university enrollment rates among the 18- to 24-year-old population increased 
from 27.3 million to over 31.2 million students (Rhode, et al., 2018) This represents a significant 
proportion of young individuals who are now eligible for catch-up vaccination and are targetable 
for behavior change intervention and protection against HPV-associated cancers (Rhode, et al., 
2018). A gender gap in vaccine uptake exists. A national study conducted in the Spring of 2015 
reported 40% of undergraduate college men had received the HPV vaccine, compared to 62% of 
their female counterparts (American College Health Association, 2015).  
Public health efforts have surprisingly neglected college-aged women in this prevention 
effort, focusing largely on preadolescent girls (Hopfer & Clippard, 2017). Although a medical 
checkup and measles, mumps, and rubella (MMR) vaccines may be required to enter college, 
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college-aged women often move through young adulthood without preventive medical visits, 
given their transitory life stage (Hopfer & Clippard, 2017). One vantage point is that college 
students represent a unique challenge for the promotion of HPV vaccine because they are less 
likely to see a health care provider and have fewer opportunities to discuss or receive a HPV 
vaccination recommendation (Rosenthal et al., 2011). Often there are too many “missed 
opportunities” to vaccinate when providers fail to make recommendations when students are in a 
health care encounter (CDC, 2019).  
Provider Recommendation Key to Vaccine Information and Uptake 
Despite calls to action by the National Foundation of Infectious Diseases (2014), there 
are no practice guidelines on how health professionals should communicate to young adult 
women or men about the HPV vaccine. It is not clear what proportion of clinicians raise or 
explicitly recommend HPV vaccination to their college-aged patients (Hopfer & Clippard, 2017). 
What is known is that providers are sources of knowledge and can influence the persuasive 
outcomes of a health message promoting HPV vaccination among young adults (Kim & Nan, 
2016). 
Health care providers, including nursing professionals, have a role in not only helping 
patients make an informed decision about starting the HPV vaccine, but encouraging completion 
of the entire series (Head, Vanderpool, & Mills, 2013).  A body of evidence shows a physician’s 
recommendation may significantly influence the vaccination decision (Daley, Liddon, Kempe, et 
al. 2006; Dillard & Spear, 2010; McRee, Gilkey, & Dempsey 2014; Jones & Cook, 2008). A 
physician recommendation is the strongest predictor of HPV vaccine receipt (Rosenthal et al., 
2011). The CDC and the President's Cancer Panel have identified improving healthcare 
providers' communication as a key strategy for increasing HPV vaccine uptake (Gilkey et al., 
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2015). Recommendations from health care providers increase patient and parent acceptance of 
vaccination (Dorrell, Yankey, & Strasser, 2011).  
Physician approval of vaccine has been cited as a predictor of vaccine uptake (Fazekas, 
Brewer, & Smith, 2008; Kasting, et al., 2016). Note much of the existing research focuses on the 
interactions between providers and adolescents and their parents. Among adolescent females age 
12 to 17 whose parents reported their provider recommended the HPV vaccine were eighteen 
times more likely to have initiated the HPV vaccine series than girls whose parents did not report 
receiving a provider recommendation (Soon, Dela Cruz, Tsark, Chen, & Braun, 2015). Ylitalo, 
Lee, and Mehta (2013) found in a national study of adolescents that those reporting vaccine 
discussions with their provider were 4.5 times more likely to report vaccine receipt.  
While scant, there is emerging research that focuses on health care provider influence 
with college student populations. This literature includes the role of the health provider as a 
trusted influence and knowledge source. The more college students trust their health care 
provider, the more they intend to get the vaccine in the upcoming year (MacArthur, 2017). In a 
study by Ragan et al. (2017) of 527 undergraduate students of those who received 
encouragement from both a doctor and parent, 95.8% received the vaccine. Kim and Nan (2015) 
found students having talked with a healthcare provider increased perceived efficacy of the 
vaccine which was related to perceptions and increased likelihood of receiving vaccine.  
Lindley et al. (2013) found females who had received a gynecological examination 
during the past year were more than twice as likely to have received the HPV vaccine. 
Marchand, Glenn, and Bastani (2012) found provider’s recommendation, expressed as having 
been ‘‘offered’’ the vaccine, was the factor most strongly associated with vaccination. In one 
study of 383 college undergraduates, 62% of females reported a health care provider had 
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recommended the vaccine to them (Bernard, et al., 2017). Women reported high levels of trust in 
particularly physicians and nurses (Garland & Quinn, 2006). Research suggests most nurses are 
supportive of HPV vaccination and are in an ideal position to provide related HPV education to 
young women compared to other clinicians (Head, Vanderpool, & Mills, 2013). 
The literature reflects an expected gender disparity in HPV knowledge and vaccine 
uptake, given that the vaccine series has not always been routinely recommended for males. 
There may be differences in communication practices of providers towards college men; yet this 
is not a developed area of the literature. Measures of knowledge and vaccine status are present, 
but with limited connections to the provider encounter.  This may reflect the timeline of HPV 
vaccine approval and recommendation for males (Patel et al., 2013).  
Some studies indicate personal biases and lack of knowledge of the guidelines for HPV 
vaccine impact healthcare provider recommendations of the vaccine to their patients (Sherlock, 
Atkinson, and Martens, 2013). Provider perception of patient risk influences vaccine 
recommendation. Some providers will not recommend the vaccine to girls perceived as not 
sexually active (Dorrell, Yankey, and Strasser, 2011). Patel et al. (2013) surveyed 4019 students; 
notably, far fewer males than females perceived either parental (46.2% vs. 68.9%) or healthcare 
provider (46.7% vs. 79.8%) approval for getting the HPV vaccine.  Beshers et al. (2015) found 
significant gender disparity regarding receiving health care provider communication regarding 
the vaccine (2.5% for males vs. 77.3% for females). Bernard et al. (2017) found males were not 
aware there was a vaccine, and only 21.6% had received a provider recommendation. More 
recently, Lee et al. (2018) found male students who have had a medical examination within the 
last year showed the greatest percentage of HPV vaccine completion. 
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Lack of provider recommendation may partially explain low vaccine uptake; but little 
literature exists with college student populations. In a study of 527 university students, 40% of 
students who were undecided about the vaccine indicated their doctor did not discuss it with 
them (Ragan et al., 2017). The importance of HPV related provider and parent communication is 
hallmark for young people who need parental consent, thus these findings are highlighted. Lack 
of provider recommendation is frequently cited by parents as reason for non-receipt or non-
pursuit of vaccination (Head, Vanderpool, & Mills, 2013; Kasting, et al, 2016; Perkins, et al., 
2014; MMWR, 2014). Dorrell, Yankey, and Strasser (2011) analyzed data from the 2009 
National, Immunization Survey-Teen (n=20,066); “…66.0% of parents reported that they did not 
receive healthcare provider recommendation for their adolescent to receive the vaccine”. Parental 
reports suggest that only about half of female adolescents have ever received a recommendation 
for HPV vaccine (McRee, Gilkey, and Dempsey, 2014). More than one in ten parents of 
adolescent girls said the vaccine was not recommended to them (KFF, 2015). Smith et al. (2016) 
analyzed the 2010 National Immunization Survey-Teen among teen girls (n=8490); health care 
provider recommendation to parents led to favorable attitudes and initiation of vaccine for their 
teen daughters, with 48.2 percentage more likely to be fully vaccinated. 
College student reported sources of HPV and HPV vaccine knowledge often include 
health care providers. Preferred information sources varied in the span of literature reviewed.  
Females reported health care providers were the most common sources of HPV information 
(Bernard et al., 2017; Bynum et al., 2011). In a study of 192 students, the main sources of 
information about HPV and the HPV vaccine were personal physicians, followed by the media, 
then family and friends (Navalpakam, Dany, Hussein, 2016). In a study of male students, sources 
included TV, radio, friends, and health education programs (Grace-Leitch, & Shneyderman, 
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2016). Male students reported the internet and school as the most common sources of HPV 
information (Bernard, et al., 2017). Social media was a preferred source among males (Bynum et 
al., 2011). For Schmotzer et al. (2013) study participants, common sources of HPV information 
were a doctor, TV commercial, high school/college course or health brochure. 
Research is needed to describe the health care provider messages that college-aged 
student report receiving about the HPV vaccine (Hopfer & Clippard, 2017). Given that the HPV 
vaccine is available at about 72% of college and university health centers nationwide, often at 
reduced cost or for free depending on students’ insurance, it is important to understand why 
students choose not to receive the vaccine to develop catch-up vaccination programs to address 
barriers and increase vaccine uptake (Ragan et al., 2017).  
HPV Knowledge and Misunderstandings Among College Students 
In this review of the past 13 years of HPV literature in college student populations, HPV 
attitudes can be interchanged with constructs of beliefs, opinions, vaccine acceptability, 
perceptions of the vaccine, and perceptions of risk of infection. Highlighted are variances in 
knowledge, frequent misunderstandings regarding HPV, and lack of perceived risk and 
susceptibility to HPV. Of particular interest is the common theme found, exemplified by 
Jozkowski and Geshnizjani’s (2016) study, where 97% of the participants were aware of the 
HPV vaccine, but did not have knowledge about where they could obtain the vaccine, why the 
vaccine is important, or what HPV actually is.  
The literature is emerging and contradictory to the expected conception that greater 
awareness and knowledge would result in vaccine intention or completion. Schmotzer et al., 
(2013) found answering questions incorrectly about HPV was associated with having been 
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vaccinated or planned to get the HPV vaccine. Significant associations between beliefs and 
vaccine status occurred when a larger proportion of people who had received or planned to get 
the HPV vaccine held misinformation (Schmotzer et al., 2013).  
Schmotzer et al. (2013) found intention to receive the HPV vaccine was not necessarily 
associated with holding correct information about HPV. So, while women may be initiating the 
vaccine, or have completed the series, they still have misperceptions and misunderstandings 
(Wolwa et al., 2013).   Indeed, historically, HPV is constructed as a ‘female’ disease (Wyndham-
West, 2016). College students hold serious misconceptions about HPV (Albright & Allen, 2018). 
Knowledge is not a direct predictor of health behavior; it is the first step in making 
informed health decisions (Sledge, 2015).  Awareness alone does not lead to positive actions 
toward health (George et al., 2020).  It has been suggested that lack of knowledge may be a 
barrier to vaccine adherence (Richman, et al., 2016). Jones and Cook (2008) found in an early 
study that increased knowledge was significantly associated with women accepting the vaccine. 
It would seem that greater perceived risk was also associated with an increased likelihood of 
intention to receive the vaccine (Jones & Cook, 2008). However, a body of the literature today is 
contradictory: knowledge alone does not equal vaccination.  
Ratansiripong (2015)found knowledge was not associated with vaccine status or intention 
in 410 men. Patel et al. (2012) found intent to undergo HPV vaccination was not significantly 
associated with any of their individual HPV-related knowledge items.  Despite high level of 
HPV-related knowledge there were not associations with intent to undergo HPV vaccination in 
their population.  Further, their education-based intervention was not significantly associated 
with HPV vaccine uptake post intervention. Only (5.5%) participants received at least 1HPV 
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vaccine dose within 6 months of study enrollment (Patel et al., 2012). McCuthceon et al. (2017) 
found similarly that after an educational based intervention, knowledge and intention to 
vaccinate was increased, but at 3 months follow up 56% of the participants remained 
unvaccinated and this is despite a reported increase in the perceived risk of contracting HPV.  
Bennet et al.(2015) conducted studied vaccine knowledge and uptake in 661 female 
university students after a tailored online educational intervention.  In a randomized control trial, 
both groups of young women received different formats of HPV education. 331 responded to 
post intervention surveys three months later. While knowledge reportedly increased, risk 
perception and intention to be vaccinated did not change significantly from baseline to 3 months 
in either group. Of participants who intended to undergo HPV vaccination at baseline, 82.4% 
remained unvaccinated 3 months later (Bennet et al., 2015). Further, knowledge change was not 
significantly associated with HPV vaccine uptake at 3 months. High baseline intent to be 
vaccinated was the strongest predictor of receipt.  
Increasing knowledge by itself is insufficient to increase vaccine uptake (i.e., behavior 
change) in the absence of additional measure such as explicit provider endorsement of 
vaccination or systems improvement to provide immediate vaccination once readiness to 
vaccinate is identified (Bennet et al., 2015). Knowledge is not a strong predictor of vaccine 
behavior. Factually driven educational interventions targeting participant knowledge have shown 
to have some impact on intention to be vaccinated but have not been associated with change in 
actual vaccine uptake. Personal or culturally tailored approaches may work by providing 
information that participants find particularly relevant (Bennet et al., 2015). 
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Richman et al. (2016) also tested an intervention among female and male students, 
sending educational text reminders for follow up vaccine appointments and measuring overall 
knowledge of HPV. Their results confirm the perplexity that although knowledge was raised, it 
was not related to follow up vaccination completion. Patel et al. (2012) conducted an educational 
intervention with 256 unvaccinated students. Among their findings were that socio demographic 
characteristics and sexual and medical history generally did not correlate with HPV vaccine 
intent, and participants who were currently sexually active were also significantly less likely to 
intend to undergo HPV vaccination.  
The literature broadly holds that females have higher HPV knowledge than males. 
Beshers et al. (2015) surveyed 817 undergraduate students at two universities in 2010. Females 
reported significantly greater awareness of HPV, the HPV vaccine, and Gardasil; significantly 
more discussions with their clinician about the HPV vaccine; and significantly higher rates of 
HPV vaccination compared to the male respondents. These differences are likely explained by 
the vaccine recommendations and availability for women only at the time. Ratansiripong (2015) 
found low HPV knowledge in 410 college males; they also had low rates of uptake. Along with 
low knowledge, only 3% of men had been vaccinated for HPV in a study by Schmotzer et al. 
(2013). 
Staggers, Mann, and Maki (2012) found evidence that while college males are aware of 
HPV “they hold a number of misconceptions, namely, their perceived lack of susceptibility and 
their ignorance of the severity of health consequences associated with HPV.” Sledge (2015) 
surveyed 86 males, eighty-five percent (n=58) of the respondents had heard of HPV and had high 
knowledge scores, but the majority did not know that there was a vaccine available for young 
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men. This was also true in a study by Gao, Okoror, and Hyner (2016) where misperceptions were 
common ranging from origin of disease, transmission, and prevention measures.   
The results of the Fontenot et al. (2014) study of 735 sexually active college males are 
particularly revealing of confusion regarding the vaccine. Lack of knowledge extended beyond 
not knowing about the vaccine to also not being aware of the disease. Similarly, many reported 
lack of risk related to lifestyle and sexual orientation/identity and believed the vaccine did not 
apply to them because they were homosexual (Fontenot et al., 2014). There was a common belief 
that the vaccine is not for men. The participants voiced confusion about whether men were 
supposed to be vaccinated or not, and some voiced a belief that this vaccine is not available for 
males (Fontenot et al., 2014). In summation, this study revealed that the college men in this 
sample had low HPV vaccine awareness, knowledge, perceived severity, and perceived 
susceptibility; thus, in part explaining lack of vaccination and intent to vaccinate. Similarly, 
Schmotzer et al. (2013) found more than half of their respondents had misinformation regarding 
men and HPV, including not knowing that there is a vaccine to protect men from HPV.  
Catalano et al.(2017) in a recent study of 256 unvaccinated undergraduate men found 
approximately one-third (31.3%) had never heard of HPV before participating in the study, and 
nearly half (45.3% had never heard of the HPV vaccine. The majority (86.3%) reported they had 
participated in some type of sexual activity therefore already at risk of HPV infection. There was 
low vaccine awareness and subsequently low intention to vaccinate using the Theory of Planned 
Behavior as a model of indication of intent. The men’s perceived social pressure to get all three 
doses of the HPV vaccine in the next 12 months was also low (Catalano et al., 2017).  
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The inaccuracy of knowledge for both genders of college student has found its way into 
the literature. In an early 2007 study, 29% of the female participants did not know if men could 
become infected with HPV and 8.8% believed males could not (Burke et al., 2010). More 
recently, of 192 students, “…75% of the participants incorrectly answered that the HPV vaccine 
can only be acquired after the age of 18 years, 71% believed that women can only contract the 
virus from a symptomatic sexual partner and 43% incorrectly believed that HPV infections lead 
to genital herpes” (Navalpakam, Dany, and Hussein, 2016). Staggers, Brann, and Maki’s (2012) 
focus groups found that males believed HPV is a problem experienced by females and that they 
are only carriers of the virus. They did not recognize that they are actually at risk for certain 
types of cancer themselves. A study found that 72.4% of 1,401 participants falsely believed that 
HPV could be cured with the right treatment (Ratanasiripong, 2012). In a study of 120 males, 
while acceptability of the vaccine was high (72%) most participants did not know the correct 
symptoms (or lack of symptoms), consequences, and/or risk factors for HPV infection (Grace-
Leitch & Shneyderman, 2016). There may also be a belief among women that they may not 
benefit from the vaccine as they get older, which is not necessarily true (Marchand, Glenn, and 
Bastini, 2012). 
Among students who state they are aware of HPV; confusion has been documented. 
Dillard and Spear (2010) surveyed 396 undergraduate women in 2008; their results showed 
misunderstandings despite a reported very high level of awareness of HPV (96%). “Although 
responses to many of the knowledge items suggest a high level of awareness of HPV and its 
consequences, other responses are cause for concern.” For example, 34% to 35% of the sample 
believed that men cannot contract HPV, There was a false belief among 42% to 45% of the 
sample that HPV and HIV have similar effects on the human body. 44% to 51% of the 
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respondents wrongly believed that the HPV vaccination is almost 100% effective in preventing 
all types of HPV infection (Dillard & Spear, 2010). Additionally, one-fourth of women in the 
Dillard and Spear study believed that because they were not sexually active, the vaccine was 
unnecessary.  Ragan et al. (2017) found in a group of 527 students, although they were aware of 
HPV, approximately one-third indicated they did not know where to get the HPV vaccine. 
Although this literature search was not primarily focused on minority perceptions 
specifically, the scant research showed college student minority groups also have low knowledge 
and confusion exists. Bynum et al. (2011) surveyed 575 African American students in 2011, 
when little research existed for this population. In their sample, there was a gender disparity in 
knowledge. Males (56.6%) were less likely than females (85.9%) to have heard of HPV and were 
significantly less likely to have heard of the HPV vaccine (65.7% vs. 95.0%) (Bynum et al., 
2011). Students were least knowledgeable about the signs and symptoms of HPV infection and a 
majority thought that HPV vaccines protect against all HPV infections (Bynum et al., 2011). 
Tung, Lu, Qui, and Ervin (2019) found low knowledge scores and lack of understanding 
about transmission and signs of HPV in Chinese students in the USA. The majority did not 
realize genital warts are caused by HPV, less than half knew the infected partner may not show 
symptoms. The majority did not know that the vaccination could be received after the age of 
18 years. The participants did not know despite a normal Pap smear, a woman may still have 
HPV infection, and many were unaware a woman still needs to get Pap smear after receiving 
HPV vaccination (Tung, Lu, Qui, and Ervin, 2019). 
Kim et al. (2017) conducted a small focus group study with Korean American female 
students in the USA to better understand their knowledge and attitude towards HPV. None of the 
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20 participants identified the HPV vaccine as a preventive method of HPV (2017). A few of 
these participants stated they were vaccinated prior to being in college because their mother or a 
health care provider had been supportive of the vaccine. Overall, the participants believed HPV 
was a woman’s disease, that the HPV vaccine was for women only, and that they were at low 
risk for acquiring HPV or cervical cancer (Kim et al., 2017).  
Perceived Susceptibility and Perceived Risk of HPV Infection 
Early on, it was thought greater perceived risk was also associated with an increased 
likelihood of intention to receive the vaccine (Jones & Cook, 2008). Despite the increased risk of 
HPV infection among college students, few studies have thoroughly examined HPV risk 
perception in this population (Patel et al., 2013). Given that HPV vaccination is now strongly 
recommended for both females and males by the CDC, it is surprising that many college students 
appear apathetic in the literature that exists. 
In a 2017 study of 383 undergraduate students, 90% of males stated they had not given 
serious thought of receiving the vaccine (Barnard, et al., 2017). Wong did not find high 
perceptions of risk in 215 unvaccinated women (2014). Similarly, for Stephens, Thomas, and 
Eaton (2016), male participants did not view HPV infection or vaccination as an immediate 
concern or priority. Thomas et al. (2016), found only 30% of young Hispanic men within their 
study believed men are at risk for acquiring HPV, and only 12% were concerned that they might 
contract an infection. 
Fontenot et al. (2014) noticed small, voiced intention to obtain the vaccine, but this was 
only after participating in the survey. Pitts and Stanley (2017) conducted structured focus groups 
with undergraduate males to understand vaccine attitudes and barriers. Several themes were 
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noted including apathy towards sexual health, dismissiveness about susceptibility, lack of 
severity of HPV, and that it was too late to vaccinate for those who were already sexually active. 
Notably in the Pitts and Stanley (2017) focus groups, there was an attitude that while many may 
have heard of HPV, they knew little about HPV. This was the same for Stephens, Thomas, and 
Eaton (2016); men rated themselves as having some knowledge about HPV and the HPV 
vaccine, yet their interview responses illustrated their actual knowledge about both was 
consistently low. For Katz et al. (2012) despite most of the male students reporting being 
sexually active and being aware of HPV, students had limited HPV knowledge and concern. 
In a study of 4019 students, only 18% of respondents believed that they were at risk of 
acquiring a genital HPV infection in their lifetime (Patel et al., 2013).  Marchand et al. (2012) 
surveyed 178 females, among those who had heard of the vaccine but had not received any doses 
(n=77), 73 % reported they had ‘never thought about’ or were ‘undecided about getting the HPV 
vaccine’. Tung, Lu, Qui, and Ervin (2019)recently surveyed 449 undergraduate students and 
found less than one-fifth believed they are susceptible to HPV infection. In another study, 
unvaccinated single women perceived themselves at zero risk for HPV, which was attributed to 
lack of sexual activity (Thompson et al., 2017). These women stated they would wait until they 
were sexually active to receive the vaccine. Hopfer and Clippard (2017) also found college 
women related HPV susceptibility primarily to relationship status.  
Fontenot et al. (2014) found male participants did not believe they were at risk for 
contracting HPV and therefore did not perceive the need to obtain the vaccine. Similarly, in 
Bynum et al.(2011) study males, were significantly less likely to perceive HPV health outcomes 
as severe and think that there was a benefit for them to undergo vaccination. Curiously, but 
contradictory to the students’ own self reports of ambiguity, HPV vaccine acceptance was 
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considerably higher than rates reported in the literature at that time (69% versus 33% to 48%). 
This is striking to note because these males also reported more unfavorable health beliefs and 
more barriers compared to the females surveyed (Bynum et al., 2011).  
Vaccination Barriers and Vaccination Intention  
As expected, females have progressed further than males towards taking observable steps 
to-wards HPV vaccination (Patel et al., 2013). Vazquez et al. (2016) surveyed 21,320 students. 
Sixty-nine percent of the females reported having received the HPV vaccine compared to 43% of 
the males. Women would appear to be stronger initiators, yet there is a return to ambiguous 
unknowns when it comes to series completion. Curiously, intention to receive the vaccine was 
unexpectedly not a predictor of vaccination uptake (Ratanasiripong, 2012). Bednarczyck et al. 
(2011) surveyed 577 college women, three hundred twenty-one (56%) women reported initiating 
the HPV vaccine series, and 255 (44%; 79% of initiators) reported completing the three dose 
series. There were 256 women who did not initiate the HPV vaccine series, 45 indicated their 
intention to receive the vaccine in the next year: 118 (46%) indicated they do not plan to get the 
vaccine in the next year, with an additional 91 (36%) unsure. Twenty-one percent of women who 
initiated the HPV vaccine, but did not complete the series (Bednarczyck et al., 2011). 
In a selective meta-analysis of college women and HPV knowledge Ratanasiripong 
(2012) found common themes related to intention. Most importantly, intention to receive the 
vaccine was unexpectedly not a predictor of vaccination uptake. Other results of the study 
follow. Normative belief and social norms, perceived severity, perceived benefits, and 
knowledge were positively correlated with intention to obtain HPV vaccine. Vaccination 
intention was also inversely associated with lack of insurance, perceived barriers, pregnancy 
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history, and riskier sexual behaviors. When HPV is only portrayed as a common infection 
(potentially reduced shame perception), female participants were more likely to indicate an 
intention to get the vaccine right away (Yang & Pittman, 2017). HPV knowledge was an 
independent predictor of vaccination intention. Normative beliefs, perceived barriers, perceived 
severity, and pregnancy history could also be predictors (Ratanasiripong, 2012). Perceived 
barriers, perceived benefits, fear of a shot, perceived severity, and self-efficacy were not 
statistically different between non vaccinated and vaccinated groups. Almost all (90%) of non-
vaccinated participants (at baseline) had neither returned to the physician nor been offered the 
vaccine, many of those intending to receive the vaccine might likely not have a chance to do so 
during the short follow-up period of 6 months (Ratanasiripong, 2012).  
Barriers to vaccine uptake early in the literature (2011) included consistent themes: 
perception of low risk of infection due to not being sexually active or being otherwise healthy, 
vaccine cost, and concerns about the safety and effectiveness of the vaccine (Bednarczyk et al., 
2011). Safety concerns, side effects, cost, not knowing enough, and lack of a health care provider 
recommendation have been reported barriers. Other frequently reported barriers included not 
being sexually active and not worried about getting HPV (Burke et al., 2010). Lack of 
knowledge, a lack of perceived susceptibility, cost, and concern about vaccine safety were given 
barriers (Katz et al., 2012). Safety concerns related to the HPV vaccine may be a major barrier to 
vaccine uptake (Bednarczyk et al., 2011). Ratanasiripong (2012) found side effects or efficacy, 
lack of information, lack of transportation, inactive sexual status, new vaccine, and lack of health 
insurance. Side effects, costs, and lack of knowledge about the vaccine were most often indicated 
as barriers to receiving the vaccine (Burke et al., 2010).   
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In the literature published after 2015, barriers include vaccine being a lack of priority, 
scheduling conflicts, and not needing to go to the doctor. Various studies noted that the reasons 
for not obtaining the HPV vaccine included cost (Kim & Nan, 2016; Sledge, 2015, Thomas et 
al., 2016).  Benefits reported were to protect themselves and their partners from infection (Pitts 
& Stanley, 2017). Perceptions of stigma and shame can be detrimental in vaccination uptake and 
serve as barriers (Yang & Pittman, 2017). Women who know that HPV is sexually transmitted 
may experience higher levels of stigma, shame, and anxiety (Yang & Pittman, 2017).  
In a focus group of women, Hopfer and Clippard (2017) found barriers including vaccine 
cost, lack of time, lack of awareness that the vaccine was available on campus, and for some, 
fear of having to discuss vaccination, and sex, with their parents. Cost, being in a monogamous 
relationship, and novelty of the vaccine were the main barriers against vaccination (Wilson, et 
al., 2016). For college males perceptions of time constraints, lifestyle norms, having fewer 
interactions with healthcare providers, and poor HPV information sources (Pitts & Stanley, 
2017) were reported barriers. Moreover, males’ perceptions of the HPV vaccination as 
emasculating, embarrassing, and stigmatizing can be barriers to vaccination acceptance (Reiter et 
al., 2011, 2014).  
College Student HPV Vaccine Decision Making 
 College presents students with opportunity for making health-related decisions for the 
first time on their own (Jozkowski & Geshnizjani, 2016).  Little research has examined how 
college students begin to make autonomous health care decisions (Barnard, et al., 2017; Ragan, 
et al., 2017). More research is needed to understand the determinants of students’ decision-
making process across healthcare factors in order to effectively incorporate interventions during 
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the transition to college (Ragan, et al., 2017). Also, little is known about the types of messages 
college women receive regarding HPV vaccination (Hopfer & Clippard, 2017) and, as a result, 
which messages will lead to vaccination.   
Young adulthood is a period for autonomous decision making regarding sexual and 
reproductive health choices (Thompson et al., 2017). Young adults are sure of their sexual 
behavior in a way parents may not be of their children’s (Wilson et al., 2016). University student 
life offers greater liberty for self-guided decision making; during this developmental period, 
young adults continue to learn how to independently manage their sexual health and are faced 
with the decision to vaccinate against HPV (Rhode et al., 2018). When teenagers enter college, 
there may be a shift in healthcare decision-making from parents and guardians to the students 
themselves (Ragan, et al., 2017).  
However, Ragan et al. (2017) noted although young adults may appear to yearn for 
independence, with regard to HPV immunization decision-making, students continue to rely 
heavily on important others while taking less of a direct decision-making responsibility for 
themselves”. Hopfer and Clippard found supportive family messages, explicit health care 
provider endorsement, and peer norms shaped the perceived benefits of vaccination among 
women (2017). Vaccinated women in this study attributed their vaccine decisions to having open 
lines of communication with their parents and being most influenced by the opinions and 
recommendations of a medical expert, almost a blind trust in their recommendation (Hopfer & 
Clippard, 2017).  
College students’ healthcare decision-making is still greatly influenced by their parents 
(Ragan, et al., 2017). Mother-daughter talk about the HPV was found to positively predict young 
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women’s HPV vaccination behavior Miller-Ott and Durham (2011). Katz et al. (2012) found that 
only a few male students (7% in their study) made independent health care decisions without 
consulting their parents. Roberts et al. (2010) found that although young women were old 
enough to receive the vaccine without their parents' consent, perception of their mother's 
approval and mother-daughter communication about sex were important predictors of 
vaccination. Influences of friends and peers are important for establishing norms, but many 
college women still turn to their parents when it comes to health matters (Kopfer & Clippard, 
2017). 
Research is needed to describe the family, peer, and health care provider messages that 
college-aged women report receiving about the HPV vaccine (Kopfer & Clippard, 2017). The 
role of parent and sibling messages in college-aged women’s HPV vaccine decisions has yet to 
be explored. There has been little documentation of decisional conflict or decisional regret 
during or after the HPV vaccine decision making process (Harper et al., 2014). Negotiating HPV 
vaccine decision-making requires deliberations, and many college women in Wyndham-West’s 
(2016) interviews were widely anxious about the decision before them. 
For Hopfer and Clippard (2017), many women have based decisions on the attitudes of 
family and health care provider messages, while having only superficial HPV knowledge. 
College women report physicians simply not mentioning the HPV vaccine or downplaying it. 
Women’s uncertainty about the HPV vaccine is understandable if not expected, given the mixed 
messages they are exposed to, and given that even clinicians sometimes provide young adult 
women with incorrect information. For Hopfer and Clippard (2017), responses indicated that 
family and health care provider messages provided vaccine decision-relevant knowledge for 
college women. However, mixed messages and the absence of an explicit recommendation by 
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health professionals to get the HPV vaccine were interpreted by college women as meaning that 
the vaccine was not necessary. 
It is difficult to say if student decision making is determined by the immediate factors 
regarding the act of vaccination or determined by more long-term benefits such as HPV 
protection. Some studies have found that vaccine decisions were not the product of an individual 
‘rational’ assessment of risk/benefit (Wyndham-West, 2016). Kim and Nan (2015) hypothesized 
that in a group of 676 students, those high in considerations of future consequences (CPC) would 
show a higher rate of HPV vaccine uptake but this was not supported. They found students that 
were high in CFC perceived the HPV vaccine to be more effective than did those low in CFC 
(Kim & Nan, 2015). Considerations of future outcomes have been shown to predict a variety of 
health-related beliefs, attitudes, intentions, and behaviors, but not HPV vaccine uptake (Kim & 
Nan, 2016). Wyndham-West (2016) found similarly a mix of delayed decision making and 
reluctance to say ‘yes’ to the vaccine, even if her interviewees voiced strong acknowledgement 
of personal risk.  
Personal Factors Related to Vaccine Intention or Uptake 
Patel et al. (2012) reviewed early HPV literature. Their collective findings suggest that 
factors beyond HPV knowledge, such as personal beliefs, attitudes, life experiences, and 
emotional states should be examined. Differences in HPV vaccine uptake exist in the literature 
surrounding topics such as demographic/descriptive characteristics: age, race/ethnicity, 
international status, relationship status, primary source of health insurance, region/location of 
college/university, membership in a sorority, and participation in varsity or club/intramural 
sports during the past year (Lindley et al., 2013; Marchand, Glenn, and Bastoni, 2012).  
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Additionally, Lindley et al. (2013) found significant differences in receipt of the HPV vaccine 
were reported based on the sexual behaviors. 
For female college students, age (older; aged 21 to 24 years), race/ethnicity, and 
international status were all found to be significantly associated with lower odds of receiving the 
HPV vaccine (Lindley et al., 2013). Lower socioeconomic status and lack of health insurance, as 
previously discussed, were likely associated with lower odds of nonwhite college women’s 
receipt (Lindley et al., 2013). Marchand et al. (2012) found that vaccinated women were 
younger, perceived the vaccine to be safer, perceived HPV severity to be lower, reported more 
social approval, more often had a doctor’s recommendation for the vaccine, and more often had a 
regular doctor compared to women who had not received the vaccine. Having prior consideration 
of a health issue may relate to stronger attitudes related to HPV vaccines (Kim & Nan, 2016). 
Women were less likely to state that their relationship status impacted their decision for 
vaccination (Thompson et al., 2017). Vaccinated single and dating women reported a more 
accurate risk perception for HPV and that their decision for the vaccine was not based on their 
relationship status (Thompson et al., 2017). 
Among male undergraduates, being sexually active or having multiple partners was 
associated with vaccine completion (Lee et al., 2018). Parents/guardians’ education and 
participant’s sexual activity status were found to be significantly related to HPV vaccination 
(Lee et al., 2018). Marital status (being unmarried), practicing organized religion, and higher 
education were also significant predictors of vaccine initiation and completion (Lee et al., 2018). 
HPV vaccine acceptance among males has been associated with being aware of HPV, being 
sexually active, having more lifetime sex partners, having a previous STI, perceiving themselves 
at risk for HPV, having a direct personal benefit, having peer acceptance of the vaccine, and 
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believing that their parents, partners, or health care providers would encourage them to be 
vaccinated (Katz et al., 2012). For males, being sexually active, having multiple sex partners, 
some HPV-related knowledge, and greater perceptions of HPV risk and susceptibility have been 
linked to greater intent to vaccinate (Gerend & Barley, 2009; Liddon et al.,2010). Heterosexual 
males appear to be less favorable toward the HPV vaccine and have less knowledge, awareness, 
and perception of control over the decision to vaccinate. Peer behaviors, perceptions of peer 
vaccination norms, and vaccination self-efficacy also increase vaccine acceptance among young 
adult males (Gerend &Barley, 2009; Hopfer & Clippard, 2011; Liddon et al., 2010; Mehta et al., 
2014; Rambout et al., 2014; Reiter et al.,2011). Ever having had sex, having had more than 5 sex 
partners, and ever having had an STD were significantly associated with men accepting the 
vaccine (Jones & Cook, 2008). 
Health Belief Model (HBM) Applied to HPV Vaccine Decision Making  
Not all studies regarding college students and HPV related knowledge, vaccine status, 
and decision making have a theoretical framework. Theory-based frameworks to understand 
determinants of health behaviors can be very helpful to understand dynamics that most influence 
intention to or actual behavior (Jozkowski & Geshnizjani, 2016). Ratanasiripong (2012) 
completed a literature review in 2010 when the vaccine had only been available a handful of 
years. Noticeably in this limited review, only 5 studies of 13 incorporated a theoretical 
framework, and the Health Belief Model (HBM) was the theory most frequently used.  
There are no current studies that have identified the precursor to action and HPV vaccine 
decision making in college students. The studies based on HBM components are not holistic, 
rather they inquire about specific constructs of the HBM. For example, Christy et al. (2016) 
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found the HBM useful to examine the extent to which commonly studied variables (i.e., 
perceived severity of HPV-related diseases, perceived risk of developing these diseases, and 
perceived benefits of HPV vaccination) had influenced the vaccine decision. 
Given vaccination activities related to perceived risk, it is possible that greater awareness 
of the impact of the HBM during studies of vaccination uptake by older adolescents and young 
adults may offer a means for better understanding and improving vaccination levels (Bednarczyk 
et al., 2011). Correlates of HPV vaccine uptake and intentions among college students have been 
studied within the framework of the HBM (Christy et al., 2016). Commonly studied cognitive 
variables include perceived risk of developing an illness, perceived benefits of taking action 
against developing an illness, and perceived barriers to taking action (Donadiki et al., 2014).  
The HBM originally attempted to explain why people fail to adopt a given preventative 
health intervention by identifying which beliefs are associated with behavior (Rosenstock, 1974). 
This model remains key in health behavior research (Glanz & Bishop, 2012). HBM predicts that 
people will likely engage in a positive health behavior when they perceive negative health 
outcomes as a real threat (i.e., severity plus susceptibility) and when the perceived benefits of the 
health behavior outweigh the perceived barriers (Pitts & Stanley, 2017). The HBM has six 
constructs that predict health behavior: risk susceptibility, risk severity, benefits to action, 
barriers to action, self-efficacy, and cues to action (Donadiki et al., 2014, Glanz & Bishop, 2012, 






Figure 1: HBM Components and Linkages (Miri, et al., 2018) 
 
Perceived Susceptibility, Severity, and Perceived Threat 
Two variables of the HBM perceived susceptibility and perceived severity—are related to 
an individual’s perceptions of a disease or health condition (Kim & Nan, 2015). These constructs 
relate to a person’s perceived threat (or risk) of disease or subsequent conditions. Additionally, 
the HBM suggests that increased severity should increase vaccination, yet in a study by 
Jozkowskia and Geshnizjani (2016) their findings suggest the opposite. There was no significant 
association between perceived severity and vaccination. 
Perceived susceptibility concerns the extent to which an individual believes that he or she 
is susceptible to a particular health problem. Susceptibility refers to the subjective risks of 
contracting a condition (Rosenstock, 1974). Individuals who feel that a given health problem is 
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more likely to afflict them tend to act on a desired health behavior (Kim & Nan, 2015). Second, 
perceived severity concerns the extent to which an individual considers a disease, or its 
consequences seriously affect him or her (Kim & Nan, 2015). This dimension includes 
evaluations of both medical/clinical consequences (e.g., death, disability, and pain) and possible 
social consequences (e.g., effects of the conditions on work, family life, and social relations) 
(Janz & Becker, 1984). Greater perceived severity of the health problem tends to result in 
stronger motivation to adopt the recommended health behavior.  
Once a person is convinced of the severity of a given health threat, then his or her 
susceptibility should be addressed. In other words, if the health threat is deemed as trivial, the 
individual will not be further motivated to make an assessment of his or her susceptibility 
(Krieger & Sarge, 2013). Severity perceptions induced by a risk message turn into susceptibility 
perceptions that in turn impact behavior or behavioral intention outcomes (Krieger & Sarge, 
2013). 
Acceptance of one’s susceptibility to a disease that is also believed to be serious was 
thought to provide a force leading to action, but not defining the particular course of action that 
was likely to be taken. This may not be the logical or recommended behavior. Again, the 
person’s beliefs about the availability and effectiveness of various courses of action, and not the 
objective facts about the effectiveness of action, determine what course he will take. These 
personal beliefs of perceived susceptibility and severity having a strong cognitive component are 
at least partly dependent on knowledge (Rosenstock, 1974). 
 At times, the concept of risk is used similarly as the term threat in the literature. Here, 
the basic assumption often is that a heightened level of risk perception should lead to more 
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protective behaviors. People’s perception of health risks influences their risk-taking or safety 
behavior is prevalent both in health behavior theories and applied health communication. 
(Gaube, Lermer, and Fischer, 2019).  
Perceived Benefits and Barriers 
Perceived benefits concern the benefits obtained by complying with the target behavior, 
often operationalized as perceived efficacy or effectiveness of the recommended behavior. 
Greater perceived efficacy or effectiveness will yield a greater probability of behavioral 
adoption. Perceived barriers concern the barriers individuals face to adopt the desired behavior, 
including monetary cost, psychological cost (e.g., inconvenience of visiting a doctor), or physical 
cost (e.g., serious side effects associated with vaccines) (Jenz & Becker, 2014).  
Self-efficacy  
Self-efficacy is the belief that one can successfully complete the behavior of interest 
despite considered barriers (Jones et al., 2014). Based originally in Bandura’s Social Cognitive 
Theory (SCT), the higher a person’s level of efficacy, the more he or she will expect positive 
outcomes to occur after performing the behavior (i.e., positive outcome expectancies), which in 
turn should motivate the person to enact the behavior (Bandura, 2004; Wong, 2014). The 
practical implication of this finding then is that interventions could be designed to increase 
young women’s perceptions of self-efficacy in talking to their doctors/parents about the HPV 
vaccine, particularly how to approach this sensitive topic when discussing it with parents (Wong, 
2014). The finding of efficacy as a central predictor of information-seeking intent speaks to the 
importance of developing interventions aimed at increasing young women’s skills to effectively 
talk to their doctors about the HPV vaccine (Wong, 2014). 
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Cues to Action 
The combined levels of susceptibility and severity provided the energy or force to act and 
the perception of benefits (less barriers) provided a preferred path of action. However, it is also 
felt that some stimulus was necessary (Janz & Becker, 1984). Cues to action refer to internal or 
external triggers that instigate behavior, and self-efficacy refers to belief in one’s ability to 
execute a health behavior (Rosenstock, 1974). Cues to action can also be an instigating event 
occurred to set the process of an action or behavior in motion. Specific cues, such as factors in 
one’s environment, can impact the final action one takes (Champion & Skinner, 2008). These 
cues to action can be internal or external, ranging from experiencing symptoms of an illness to a 
health care providers recommendation. 
Rosenstock (1974), who created the HBM, spoke of the value of cues to action, but the 
unfortunate difficulty in isolating them as a cause of behavior. Those who have taken a 
recommended action in the past will probably be more likely to remember preceding events as 
relevant than will respondents who were exposed to the same events but never took the action. 
These problems make testing the role of cues most difficult in any retrospective setting. 
Health Belief Model (HBM) Applied to Attitude and Vaccine Decision  
Research exists using constructs of HBM when examining college student HPV 
knowledge, attitude, and vaccine decision. Sledge (2015) found in a review of the literature a 
limited number of studies used selected constructs of the HBM model to understand the relation 
to HPV and HPV vaccination. The HBM has been used extensively to study other types of 
vaccination beliefs and behaviors and has also been used in vaccination research to identify 
patients' perceptions of disease and vaccination (Donadiki et al., 2014). The HBM can also be 
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used to explain which beliefs should be targeted in communication campaigns to cause positive 
health behaviors (Carpenter, 2010, Thomas, Dalmida, and Higgins, 2016). 
HBM indicates the decision to vaccinate is a balance between the perceived risk of 
disease severity including its health and social consequences as well as the benefits/harms of 
vaccination (Harper et al., 2014). Studies also expand on the HBM, including additional 
variables of interest such as intention and personal values. Susceptibility and self-efficacy have 
been positively related to their intention to talk to a health care provider (Katz et al., 2012). 
Women with a clear sense of what their personal value of HPV vaccination was (accept/reject) 
were highly satisfied with their decision (Harper et al., 2014). Intention has been positively 
associated with their likelihood of obtaining the HPV vaccine (Katz et al., 2012).  Catalano et al. 
examined expectations, HPV knowledge, self-efficacy to get the HPV vaccine, situational 
perception, self-control to get the HPV vaccine, and self-efficacy in overcoming barriers to get 
the HPV (2017).  
HBM suggests that a person will take part in a health-promoting behavior if that 
behavior's benefits outweigh the consequences of that behavior (Burke et al., 2010).  Studies 
oriented to the HBM have identified that, if HPV is not evaluated as a risk to personal health, it 
is less likely that individuals will take actions to protect themselves (George, et al., 2020). The 
HBM leads us to conclude that females are most likely to acquire the HPV vaccination if the 
perceived threat of HPV and the benefits of the vaccination are high while there are few 
perceived barriers (Burke et al., 2010). Greater perceived barriers to HPV vaccination and fewer 
perceived benefits of vaccination have been associated with non-receipt of the HPV vaccine 
among female college students (Donadiki et al., 2014). Self-efficacy increases intentions of 
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female students to talk to their doctors about the HPV vaccine by increasing response efficacy, 
unless perceptions of both susceptibility and severity are relatively high (Krieger & Sarge, 2013).  
As the HBM predicts, believing that HPV/HPV-related diseases are serious conditions 
increases the likelihood that an individual intends to get the vaccine; believing that the HPV 
vaccine is effective also increases individuals’ intent to receive the vaccine (MacArthur, 2017).  
As the HBM indicates, health beliefs are direct and proximate correlates of HPV intentions 
(MacArthur, 2017).  The more women perceive themselves susceptibility to cervical cancer, the 
more likely they are to engage in screening seeking behaviors (Wolwa et al., 2013). Women who 
perceived the benefit of screening and believed cervical cancer could be prevented were more 
likely to have a Pap test, but not necessarily the vaccine (Wolwa et al., 2013). Sledge (2015) 
found perceived barriers of HPV vaccination were a unique predictor of intention to receive the 
HPV vaccination. Although a young man may fully understand the benefit of the HPV vaccine, 
if he perceives the barriers to getting the vaccination to be great, then the chances that he will 
receive it are decreased. 
Grace-Leitch and Shneyderman (2016) believe HBM constructs offer some explanations 
for why rates of HPV vaccine initiation and completion tend to be low, although rates of 
acceptability and vaccine intention have been high among college males. In their study, 
perceived susceptibility was positively associated with vaccine acceptability. Thus, those 
participants who thought they were more susceptible found getting the HPV vaccine more 
acceptable (Grace-Leitch & Shneyderman, 2016). Those who did not deem themselves at risk 
did not intend to vaccinate. Steggers, Mann, and Maki (2012) used the HBM to understand male 
perceptions of HPV. The lack of perceived susceptibility and severity of HPV for men were a 
barrier to getting vaccinated. Their participating males did not feel they needed to get vaccinated. 
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While benefits were acknowledged, like protecting partner health, the males were still hesitant to 
vaccinate. The barriers mentioned were time, cost, and perceived side effects (Steggers, Mann, 
and Maki, 2012). College-aged males must first determine their personal risk of HPV infection. 
This perceived threat may be influenced by personal beliefs, previous behaviors, and practices 
related to sexual behavior (such as multiple sexual partners, use of condoms, and preexisting 
HPV knowledge) (McCutcheon et al., 2017). 
Christy et al. (2016) found women’s HPV vaccine intentions were positively related to 
perceived risk of developing genital warts or an HPV-related cancer, perceived benefits with 
respect to genital warts and cancer risk reduction, and anticipated regret if one were 
unvaccinated and later developed genital warts. Higher levels of HPV knowledge and a 
subsequent increase in perceived risk of becoming HPV-infected also lead to higher levels of 
intention to receive the vaccine especially in women (Jones & Cook, 2008). Grace-Leitch and 
Shneyderman (2016) surveyed 120 male students. With this group, HPV vaccine acceptability 
proved quite high, and perceived susceptibility to HPV, as well as self-efficacy as it pertains to 
communication with a sexual partner about contraceptives, were both found to be significantly 
associated with vaccine acceptability. Jones and Cook (2008) also found higher perceived risk of 
getting HPV was associated with both men and women intending to receive the vaccine. 
Contradictions Within Applications of Health Belief Model  
Several studies use the specific HBM constructs of susceptibility, severity, and threat (or 
risk). The paradox in the literature is that the model shows predictive behavior when threat is 
high for some studies, and for others, it does not. High levels of perceived threat and/or risk of 
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HPV infection do not impact reported intention to vaccinate, contrary to the model’s prediction. 
Examples of these contradictions in the literature follow.  
Even when perceived self-efficacy and response efficacy were high, increasing levels of 
severity when susceptibility was high decreased intentions to talk to a physician about the HPV 
vaccine (Krieger & Sarge, 2013). That is, if a college-age female perceives herself to be highly 
susceptible to HPV and perceives HPV to be rather severe (Krieger & Sarge, 2013), 
theoretically, she would respond towards communication, information seeking, or vaccination. 
Krieger and Sarge (2013) note that very high levels of threat may not result in adaptive behavior 
regardless of efficacy. It is concerning that many women appear decisionally neutral towards the 
vaccine (Harper et al., 2014). 
Knowledge and attitudes toward the vaccine were not directly associated with the 
outcomes of vaccination status and intention (Ratansiripong, 2015). Knowledge may impact 
perceptions of severity and susceptibility. Women surveyed by Thompson et al. (2017) “…were 
cognizant of the potential change in risk for HPV based on changing relationships, these were 
not motivating factors when the women evaluated their potential risk for HPV. In other words, 
women were evaluating their current risk for HPV; rather than recognizing the potential for that 
risk to change in the future (Thompson et al., 2017).   
Krieger and Sarge’s (2013) findings contradict HBM predictions. Even when perceived 
self-efficacy and response efficacy were high, increasing levels of severity when susceptibility 
was high decreased intentions to talk to a physician about the HPV vaccine. That is, if a college-
age female perceives herself to be highly susceptible to HPV and perceives HPV to be rather 
severe (Krieger & Sarge, 2013), theoretically, she would respond towards communication, 
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information seeking, or vaccination. Krieger and Sarge (2013) note that very high levels of threat 
may not result in adaptive behavior regardless of efficacy. Self-efficacy increases intentions of 
female students to talk to their doctors about the HPV vaccine by increasing response efficacy, 
unless perceptions of both susceptibility and severity are relatively high (Krieger and Sarge, 
2013). Once a person is convinced of the severity of a given health threat, then his or her 
susceptibility should be addressed. In other words, if the health threat is deemed as trivial, the 
individual will not be further motivated to make an assessment of his or her susceptibility 
(Krieger & Sarge, 2013). Severity perceptions induced by a risk message should turn into 
susceptibility perceptions that in turn impact behavior or behavioral intention outcomes (Krieger 
& Sarge, 2013). 
Navalpakam, Dany, and Hussein (2016) found the majority of the participants agreed that 
the HPV infection is a serious and life threatening (79%); however, 50% of the participants did 
not believe that they themselves were at a risk of contracting HPV. In a study by Christi et al. 
(2016) of 233 unvaccinated students, neither HBM variables, nor prior awareness of the HPV 
vaccine, were associated with male or female vaccine intentions. Among women, only perceived 
benefits with respect to cancer risk reduction showed consistent associations with HPV vaccine 
intentions (Christi et al., 2016). Among women, perceived severity of HPV-related diseases was 
consistently unrelated to HPV vaccine intentions, as found in prior research (Christi et al., 2016, 
Donadiki et al., 2014). 
Perceived threat and actual risk may not align. In a study of 214 students, ethnicity, 
history of sexual activity, and number of sexual partners were not associated with receiving or 
planning to receive the HPV vaccine (Schmotzer et al., 2013). Ratanasiripong (2012) also found 
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a history of having vaginal sex, unprotected sex with a casual partner, and numbers of sexual 
partners were not associated with vaccination status.  
Higher uptake of HPV vaccine in those reporting a history of sexual activity may indicate 
that perceived risk of this sexually transmitted virus may be a particularly important motivator to 
receive the vaccine (Bednarczyck et al., 2011). However, for Jones and Cook’s (2008) study, 
vaccine acceptance was not significantly associated with age, race, recruitment setting, ever 
having HPV or genital warts, or perceived severity of HPV. Unvaccinated single women 
perceived themselves at zero risk for HPV, which was attributed to lack of sexual activity 
(Thompson et al., 2017). Perceived severity of HPV infection or cervical cancer has not emerged 
as a correlate of vaccine acceptability in women (Gerend & Barely, 2009).  
Criticisms of Applied Health Belief Model  
The literature includes constructs of health behavior theories, yet there is no consensus on 
which constructs are predictive of vaccine uptake and decision making. The implications are that 
other models may better understand vaccine decision making and intention. Combinations of 
variables are therefore more evident in the literature, with incorporation of constructs from 
various theories. Glanz and Bishop (2012) believe researchers may pick and choose variables 
from different theories in a way that makes it difficult to ascertain the role of theory in 
intervention development and evaluation. The HBM does not specify how constructs of the 
model interact with one another. Therefore, different operationalizations of the theoretical 
constructs may not be strictly comparable across studies (Ulrich, N.D.) 
Criticisms of the HBM are that self-efficacy is rarely included in HBM studies and the 
variables are hierarchically situated so that some moderate the meditational influence of others 
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(Jones, et al., 2014). Other studies have shown that the HBM is not sufficient to predict behavior. 
There was a weak relationship between subjects’ estimate of how severe a given negative health 
outcome would be and their likelihood of adopting the target behavior. Additionally, the 
relationship between susceptibility beliefs and behavior was near zero (Jones, et al., 2014). 
The HBM alone may not be the ideal theoretical framework for understanding vaccine 
decision making. Glanz and Bishop (2012) offer compelling insight in applying any theory to 
research. The strongest interventions may be built from multiple theories and there is no 
substitute for knowing the audience. Others suggest using constructs of several theories to best 
explain vaccine behaviors (Jozkowskia & Geshnizjani, 2016). Examples of other theories include 
The Reasoned Action Approach (RAA), the most recent formulation of the Theory of Reasoned 
Action, the Theory of Planned Behavior (TPB) and the Integrated Model (Fishbein & Ajzen, 
2010).  
According to the RAA, a woman’s intention to engage in a behavior depends on her 
attitude towards the behavior, her perceptions of the norms of important individuals and similar 
others (i.e., perceived norms) and her perceived behavioral control (Jozkowski and Geshnizjani, 
2016). The TPB model is highly predictive of human action. Specifically, the TPB posits that 
attitude, subjective norm, and perceived behavioral control influence behavioral intention, and 
subsequently, behavior (Catalano et al., 2017). TPB posits that intention is the main precursor to 
health behavior. TPB claims that attitude (the degree to which a person has a favorable or 
unfavorable evaluation of the behavior), subjective norm (normative influences; the perceived 
social pressure to perform or not perform the behavior) and perceived behavioral control (PBC; 
the perceived ease or difficulty of performing the behavior of interest) predict intention 
(Juraskova et al., 2012). A person’s behavior is determined by their intention to perform the 
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behavior and that this intention is, in turn, a function of their attitude toward the behavior (Patel 
et al., 2012). 
An alternative theory is The Consideration of Future Consequences (CFC), a concept 
coined by Strathman and colleagues (1994), is defined as ‘‘the extent to which individuals 
consider the potential distant outcomes of their current behaviors and the extent to which they 
are influenced by these potential outcomes’’ (Kim & Nan, 2015). Individuals with high CFC are 
more likely to adopt preventive health behaviors than are those with low CFC (Kim & Nan, 
2015). Theories in risk communication address the formation of risk perception, such as the 
protection motivation theory (Neuwirth, Dunwoody, & Griffin, 2000) or the risk information 
seeking and processing model (Nan et al., 2015).  
Rationale for Proposed Study 
Healthy Campus 2020 provides a framework for improving the overall health status on 
campuses nationwide. Included in their objectives are to increase the proportion of students who 
report receiving human papillomavirus/HPV vaccine (American College Health Association, 
2019).  Yet, there exists a significant gap in vaccine coverage of the human papillomavirus 
(HPV) among college-aged students (Rohde et al., 2018) that has not been explained. 
These gender gaps also exist in knowledge, although inconsistencies in the literature 
support the belief that knowledge is not directly linked to behaviors (Ajzen, 1991). Thus, raising 
knowledge or awareness regarding the vaccine may not adequately promote uptake (Christy et 
al., 2016). Given the main outcome of interest is HPV vaccine uptake, it is important to 
understand why college students’ perceptions of susceptibility and severity and subsequent threat 
are not leading to higher uptake rates. 
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A body of evidence shows a physician’s recommendation may significantly influence the 
vaccination decision (Daley, Liddon, Kempe, et al. 2006; Dillard & Spear, 2010; McRee, Gilkey, 
and Dempsey 2014; Jones & Cook 2008). They have a role in not only helping patients make an 
informed decision about starting the HPV vaccine, but encouraging completion of the entire 
series (Head, Vanderpool, & Mills, 2013).  Despite calls to action by the National Foundation of 
Infectious Diseases (2014), there are no practice guidelines on how health professionals should 
communicate to young adult women or men about the HPV vaccine. Provider communication 
may act as a cue to action that permits women to realize actual risk for HPV and facilitate the 
vaccination process (Thompson et al., 2017).  However, there is little or no literature that 
captures the messages health providers give to college students. This study was intended to 
memorialize themes present in provider communication to both female and male college students 
regarding HPV information and vaccine need. 
This study sought to understand college student HPV and HPV vaccine knowledge, 
vaccine status, and messages received from their health care provider. Specifically, what was the 
level of perceived personal risk of HPV infection and related outcomes? Given the greater 
awareness of the vaccine among women relative to men and previously documented gender 
differences in behaviors related to disease prevention (Christy et al., 2016); this study sought to 
understand if gender differences would be found in HPV and HPV vaccine knowledge scores 










 This study collected primary data from a self-administered survey questionnaire 
distributed to undergraduate college students at Oklahoma State University (OSU). A 
quantitative survey was be used to evaluate student knowledge. Qualitative questions were 
included to gather student perspectives on provider influence on HPV vaccine decision and 
provider information sharing about HPV.  The project was submitted to OSU’s Institutional 
Review Board (IRB) and approved. The data collection window was for one month post IRB 
approval. 
OSU’s Institutional Research Analytics (IRA) system provided 5,000 student emails 
based on inclusion criteria of being a currently enrolled student between the ages of 18-24.  Of 
the 5,000 total emails, 3,000 emails were sent to male students and 2,000 were sent to female 
students. Four of these emails were undeliverable. A recruitment email was sent with consent 
and link to a web-based, self-administered questionnaire using a Qualtrics online survey tool 
(http://www.qualtrics.com/). Emails were distributed via the OSU system in effort to be 
positively received by students as a recognized email domain. The OSU IRB recommended 
social distancing options for data collection; a self-administered online questionnaire was 
appropriate to ensure student safety.
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 The data collection window was for one-month post IRB approval aiming to reach the 
desired participant sample size (n=500). A reminder email was sent 2 weeks after the initial 
email to prompt non-respondents. IRB approval was received to distribute only one reminder 
email. Using data collection by Qualtrics was strategic in this study to provide tracking and 
recording of results. Features in Qualtrics survey tool allowed for exporting of results to SPSS 
software. The Qualtrics survey was created to align with these features. 
Participants  
 Study participants were 254 currently enrolled female and male undergraduate students at 
OSU that were between 18 and 24 years old. Respondents were primarily white/Caucasian 
(n=188; 76.7%) female (n=167; 68.2%) students from suburban (n=134; 57.7%) and rural areas 
(n=69; 28.2%) during their adolescence. Per CDC and ACIP recommendations, college students 
in this age range have been vaccine eligible, are within range to still receive the vaccine, and 
health providers have been encouraged to make recommendations to this population (President’s 
Cancer Panel, 2018). Any level of undergraduate enrollment status was eligible. To ensure 
eligibility, the survey included an early eligibility question and answer prompt to prevent survey 
completion if the student was not 18-24 years old at time of survey distribution. A full graphic of 
gender, race/ethnicity, place of residency as an adolescent, and undergraduate status is presented 
in Table 1. 
Compensation for Participation 
Participants were able to choose to enter a drawing for Amazon gift card lottery drawing. 
Two hundred dollars were distributed randomly, the amounts given were 1:$50, 2:$25, 10:$10. 
To be eligible to receive the lottery prize, students needed to provide their OSU email address 
when prompted at end of survey completion. Odds of receiving a gift card were dependent on the 
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total number of respondents that opted in for the drawing. Some participants did not receive 
compensation. Electronic gift cards were distributed two weeks after data collection ended.  
Survey Instrument 
After consent, the following demographics were collected at the beginning of the survey: 
age, gender, race/ethnicity, hometown at adolescence, and undergraduate college level 
classification. Students were asked in a close-ended question ‘What is your HPV (Human 
Papillomavirus) vaccine status?’ Answer choices were partially vaccinated (some doses), fully 
vaccinated (all doses), not all vaccinated, or unsure. The instrument included qualitative 
exploratory open ended response questions and a then group of HPV knowledge statements for 
which students could indicate true, false, or I don’t know. The study included two questions 
regarding student perceived risk of contracting HPV. 
Exploratory questions. There were two exploratory qualitative questions to gather what 
communication messages were received from health care providers that influenced respondents’ 
decisions to vaccinate or not vaccinate. All respondents were asked to recall provider 
communications received.  Open ended questions allowed students to respond with their answers 
to two exploratory questions: (a) What information has a health care provider given you about 
HPV? (b) How did the health care provider influence your decision about HPV vaccination?  
Student perceived risk and HPV knowledge. Respondent perceived risk was assessed 
by asking for a comparative judgment: “Compared to other people my age, I think that my 
chance of getting HPV is…” much below average, below average, average, above average, much 
above average. This format has been used and adapted in previous studies (Marlow, Waller, and 
Wardel, 2009; Nadarzynski, Waller, Rob, and Marlow, 2012). Respondents were then asked an 
open ended question: “What factors influence your chance of getting HPV?” 
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Waller, Ostini, Marlow, McCaffery, and Zimet (2011), developed and validated their 
HPV Knowledge Survey, a 29-item scale measuring knowledge of HPV, HPV testing, and HPV 
vaccination based on previous literature and expert consultations. At the time, Waller et al. 
(2011) observed in HPV research there had been a tendency for each study to develop a new 
measure of knowledge, with minimal psychometric evaluation. Their instrument was found to 
have good internal consistency (α=0.849) and test–retest reliability (test–retest=0.62 and 0.69) in 
an internet-based study of 2409 adults internationally. Total scale reliability was α=0.838. 
General HPV knowledge questions were grouped: 1) health consequences of HPV; 2) 
HPV and cervical screening; 3) symptoms; 4) causes, risk factors and transmission; 5) prevention 
and treatment; 6) prevalence; and 7) testing/vaccination. Refer to Appendix 1: Knowledge 
Instrument. Twenty-six knowledge questions from the Waller et al. (2011) instrument were used 
in this current study. Respondents could answer true, false, or don’t know to the items. Question 
‘The HPV vaccine requires three doses’ was not used from the original instrument, as dosing 
protocols have changed over the generations of vaccines. There were 16 ‘true’ answers and 10 
‘false’ answers. The knowledge score was determined by the number of total correct answers 
provided. The higher the number of correct answers provided, the higher the knowledge score; 
and similarly, the lower the number of correct answers, the lower the knowledge score.  
Data Analysis 
Statistical Package for the Social Sciences software (SPSS) was used to analyze 
quantitative data collected in this study. Descriptive statistics were used to present student 
demographics and vaccine status. Scores for knowledge were generated. An independent 
samples T-tests was used to compare student knowledge scores by gender. Chi-square tests were 
used to compare student perceived risk by gender and student perceived risk by vaccine status. 
An ANOVA was performed to compare knowledge scores by vaccination status. 
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After answering demographics and background questions, 157 respondents answered one 
or more of the qualitative exploratory questions and completed the knowledge questions; these 
written responses were analyzed. Responses were saved in an excel file format, for each of the 
three exploratory questions. For each question, responses were then read and individually coded 
by themes adding new codes as needed. For the question ‘What factors influence your chance of 
getting HPV? apriori themes were created based on the literature HPV vaccine benefits, risk of 
HPV disease, cancer prevention, recommendation of provider. The excel file was used to 
organize and track findings of the common themes/codes. Findings by theme were then reported 
with selected representative quotes to illustrate participant responses and capture diversity of 


















This chapter presents results from the analysis of data. There are four sections of results 
that align with the study research questions: student HPV vaccine status, HPV knowledge scores, 
student perception of risk, and how health care provider communication to college students 
influenced the vaccine decision (including what information was shared). 
HPV Vaccination Status 
Students were asked to report their vaccination status.  Eleven students (4.5%) reported 
they were partially vaccinated; these students were combined with the fully vaccinated group 
(n=129; 52.7%) for all analyses and are designated as fully/partially vaccinated here forward. 
Vaccination status categories were ‘unsure if vaccinated’ (n = 78; 32%), ‘not at all vaccinated’ 
(n=26; 10.7%), and ‘fully/partially vaccinated’ (n=140; 57.4%). It was hypothesized that female 
students would have higher HPV vaccine initiation and completion than male students. The 
vaccine rates by gender were ‘unsure if vaccinated’ (female n = 51; 20.9%; male n = 27; 11.1%), 
‘not at all vaccinated’ (female n=17; 7%), male (n=9; 3.7%), ‘fully/partially vaccinated’ (female 
n=99; 40.6%; male n=41;16.8%). To determine if vaccination status varied by gender, a chi-
square test of independence was run. Prior to analysis, one participant was removed from the 
sample as they indicated being transgender. The hypothesis was not supported by the chi-square 
test; there was no significant difference by gender [X2(2, N= 244) =.785, p =.675]. (See Table 2).
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HPV Vaccine Recommendation Status  
Students were asked if a health care provider had ever recommended an HPV vaccine to 
them. Over half of the students indicated they had received a recommendation (n=142; 58%). To 
determine if provider HPV vaccine recommendations were different by gender a chi-square test 
of independence was performed. The patterns of provider recommendation were significantly 
different by gender [X2(1, N= 242) =4.563, p =.033].  The pattern among students receiving 
provider recommendations was higher for females (n=61; 63.3%) than males (n=39; 48.7%).  
To determine if provider recommendations differed by student residence at adolescence, 
a chi-square test of independence was performed. Prior to analysis, the categories of urban and 
extra-large city were combined. Categories for hometown were suburban (n=134; 57.7%) rural 
(n=69; 28.2%) , urban (n=42; 17.1%). There were no significant differences in recommendations 
by where students reported they were raised [X2(2, N= 243) =9.69, p =.616]. 
HPV Knowledge Scores 
 Total knowledge scores were calculated by sum of total correct answers provided, the 
possible range 0 to 25. Participants who had incomplete or missing answers were not included in 
calculations or analysis. The overall mean score was 12.2 (SD=6.14); and the mean score was 
slightly higher for females (M=12.5; SD=5.94) compared to males (M=11.4; SD= 6.65). Only 
twenty students had a total score of twenty or greater, one student got all items correct.  
Table 8 presents percentages of correct individual knowledge items for comparison. 
Upon review of each knowledge statement, differences in content knowledge exist. Overall, 
students scored highest on the knowledge statements that related HPV to sexual behaviors: 
Having many sexual partners increases the risk of getting HPV (84.4%), HPV can be passed on 
during sexual intercourse (81.1%), and Using condoms reduces the risk of getting HPV (72.8%). 
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However, these high scores were not consistent for all statements related to sexual behaviors. For 
example, only 54.4% correctly knew HPV can be passed on by genital skin-to-skin contact. 
For thirteen of the twenty-five questions, students had the lowest percent correct (below 
41.9%). Students knew least about HPV screening and testing, total percent of correct answers 
for three of these statements ranged from 10.7% to 15.2%, (i.e. HPV usually doesn’t need any 
treatment; When you have an HPV test, you get the results the same day; If HPV test 
shows…woman does not have HPV, her risk of cervical cancer is low). Students did not score 
well on the statement: Most sexually active people will get HPV at some point in their lives 
(25.4% correct). Students scored low on statements related to the benefits and timing of the 
vaccine, only 24.7% scored correctly for both of these items: HPV vaccines are most effective if 
given to people who have never had sex and HPV vaccines offer protection against most cervical 
cancers. 
An independent samples T-test was used to determine if total knowledge scores were 
significantly different by gender. It was hypothesized that females would have higher knowledge 
scores than males. However, this was not supported by the T-test analysis. There was no 
significant effect for gender [t(177) = 2.214, p =.139]. Additionally, a one-way ANOVA was 
used to examine whether where students were raised (e.g., suburban, rural, urban) impacted total 
knowledge scores. There was no significant difference at the p <.05 level for the three conditions 
[F(2,177) = .973, p =.380].  
 It was predicted that there would be differences in HPV knowledge scores according to 
vaccine status; this was supported. A one-way ANOVA was used to analyze the effect of 
vaccination status on total knowledge scores. There was a significant effect of vaccination status 
on total knowledge scores at the p <.05 level [F(2,177) = 4.495, p =.012]. (See Table 4). Post hoc 
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comparisons using the Tukey HSD test indicated that the mean total knowledge scores were 
significantly higher for both the fully/partially vaccinated (M=12.86) and not at all vaccinated 
(M=13.7) compared to the unsure group (M=10.11).  
Student Perceived Risk of HPV Infection 
 Participants were asked to self-report their perceived risk of contracting HPV using five 
response choices: much above average (n=1; .5%), above average (n=5; 2.6%), average (n=52; 
27.1%), (below average (n=57; 29.7%), and much below average (n=77; 40.1%). There were not 
sufficient responses for the much above average and above average categories; therefore, these 
categories were added to the average category. Three categories were used for analysis: average 
(n=52; 28%), below average (n=57; 30.6%), and much below average (n=77; 41.4%). It was 
hypothesized that students who had started the vaccine or completed the vaccine series would 
have lower perceived risk of infection than those not vaccinated. This was supported in the 
analysis. A chi-square test of independence was performed to examine student perceived risk and 
their vaccine status. There was a significant vaccine pattern across student perceived risk [X2 (4, 
N=186) =10.164, p = .038]. (See Table 3).  Fully/partially vaccinated students were more likely 
to report their perceived risk as much below average (n=50; 48.1%) or below average (n=30; 
31.7%) compared to the students who are unsure of their vaccination status (n=17, 28.8%). 
Students who were unsure of their vaccine status were more likely to view their risk as average 
(n=25, 42.4%) compared to the fully vaccinated/partially vaccinated (n=21, 20.2%) and not at all 
vaccinated students (n=6, 26.1%).  
         Two separate chi-square tests of independence were performed to see if there were 
differences in perceived risk by gender or race/ethnicity. There were no significant differences in 
level of risk perception by gender [X2 (2, N=185) =3.846, p = .146]. Race/ethnic group 
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classification was reported by students. The respondents were mostly white/Caucasian (n=188; 
76.7%). The other categories were combined into one minority category due to the low number 
of responses within each of the separated categories: American Indian (n=15; 6.15), Asian 
(n=12; 4.9%), Black/African American (n=6; 2.4%), Hispanic (n=17; 6.9%), Native Hawaiian or 
Pacific Islander (n=1; .4%), Bi-racial (n=6; 2.4%). For data analysis, the white and minority 
categories were compared, there were no significant differences in level of risk perception by 
race/ethnicity [X2 (2, N=186) =2.750, p = .253].  
Health Care Provider Communication About HPV 
A focal point of this study was to collect college student perspectives on how HPV and 
HPV vaccination is communicated by health care providers to them. The survey instrument 
contained three sections (demographics, knowledge quiz, and exploratory questions); 157 
students completed all three sections. The analyses presented below include only complete 
student responses (i.e., students who completed all three sections of the survey). Findings for the 
three open ended questions were separately transcribed, and responses were coded by themes. 
This provided an overview of the student responses. Each line of transcribed student response 
was coded manually for each question.  
Information sharing about HPV and HPV vaccination. Students were asked what 
types of information their health care provider had shared about HPV or the HPV vaccine. Table 
5 provides a summary of these results. Upon review of the responses, there appears a strong 
separation between students who did not recall provider communications (n=63; 41.7%) and 
those who had spoken to their provider about HPV (or the HPV vaccine) (n=77; 51%) . For 
students who recalled a provider conversation, they received vaccine recommendations presented 
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with HPV education. A small group indicated they were vaccinated when younger, therefore the 
provider addressed conversations to the parent, not to them.  
Most student (female n = 41, male n = 22) responses included having not received any 
information from a provider. Students answered, “I do not know”, “I do not remember”, or they 
had no provider conversations about HPV. One student recalled, “Nothing. I’ve never had a 
health care provider tell me about HPV.” Similarly, another said, “I have not received any 
information about it.” Some students stated they do not know what HPV is: “I haven't even 
heard of HPV before this survey.” Similarly, a student said, “I have heard nothing and am 
actually unsure of what it is.” 
For students recalling provider communications, there were specific educational 
messages and information sharing related to the nature of HPV and that a preventative vaccine 
was available. Many students (female n=44, male n=5) stated their provider spoke of prevention, 
or specific prevention of cervical cancer with one participant indicating, “that it is good for both 
men and women to get. The FDA recommends it. It is effective in preventing HPV which can lead 
to cervical cancer.”  
Additionally, some students (female n=15, male n=7) received a specific provider 
recommendation for the HPV shot with information, such as receiving a pamphlet or that HPV 
was a sexually transmitted infection, such as “this vaccine prevents one of the most common 
forms of STIs and is important to get”. Another student stated, “They gave me paperwork that 
talked about the benefits of having the HPV vaccine. Mainly they emphasized how it won't 
necessarily harm me, but I could harm a future girlfriend for a partner in the future without it.”  
  A small group of 11 students (female n=11, male n=2) stated the communication was 
directed towards their parents when they were younger and explained that is why they do not 
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know about HPV. An example of this mindset is, “my mom was who they talked to at the time of 
the vaccine, so I have no idea what it's about.”  
Another group of students indicated they do not know what HPV is, despite having seen a 
health care provider. For example, one student said, “I still don’t know what HPV is.” There were 
6 students (female n=2, male n=4) that recalled receiving a vaccine recommendation, but without 
any HPV information provided with one student reporting they were told that “a vaccine will 
reduce my chance of getting it, although I was never really told exactly what it was.” 
Influence on college student HPV vaccination decision making. When asked “how did 
the health care provider influence your decision about HPV vaccination?” student responses   
aligned with four distinct experiences: (1) provider approval, (2) not applicable, (3) no influence, 
and (4) parent made decision.  
A group of 30 students (female n=19, male n=11) indicated the provider had not 
influenced them. This set of responses also included statements such as “none” or “N/A”. 
Reviewing the data set closer, none of these 30 students had received a provider recommendation 
for the vaccine, which provides context for their open-ended responses. Twenty-six students (19 
female, 7 male) stated their provider “didn’t influence me” or that their provider “didn’t bring it 
up.” Of these students, 18 had not received a vaccine recommendation and four  students (female 
n=1, male n=3) stated they did not get the shot. 
Most students (female n=41, male n=12) relayed confidence in receiving a provider 
recommendation for the vaccine. The narratives implied they had made vaccine decisions based 
on provider communications directed towards them. For example, one student said, “a big 
influence, would never have known about the risks otherwise.” The favorable approval of the 
provider for the vaccine was a salient theme. One student recalled, the provider “… influenced 
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my decision because he is an expert regarding health.” Students in this group also provided 
examples of education messaging partnered with the vaccine recommendation that favorably 
influenced them. An example of this provider recommendation with information shared is within 
this student quote: “they recommended I receive it to protect myself against cervical cancer.” 
Table 6 provides a summary of these responses.  
Another theme from the student responses was that parents were the vaccine decision 
maker. Most of these 21 (female n=17, male n=4) students indicated they had received the 
vaccine when they were young. They stated their mother was the primary information source or 
decision maker: “I didn’t decide my mom did.” Another student recalled, “He [referring to her 
provider] didn't influence my opinion either way. My mother influenced me to get it.” 
Perspectives on factors that influence contracting HPV. Participants were asked, 
“What factors influence your chance of getting HPV?” The responses were coded for thematic 
analysis. A group of students clearly stated that “I do not know” (n=22; 16.7%). Another small 
group provided erroneous answers or had mis-read the question prompt. Among the rest, 
multiple different perspectives were voiced; some answered by broadly identifying risk factors 
and others took a more personal approach by relating the question to their own behaviors. 
Participant responses were coded using both apriori and emergent themes. Apriori themes for 
organizing student answers included risk factors, specifically related to being sexually active, 
and engaging in sexual behaviors and protective factors, such as having the vaccine or being a 
virgin (or celibate). These thematic categories used to organize student responses into two 
overarching themes: risk factors and protective factors. 
An expected overarching theme relating to HPV risk factors was engaging in risky sexual 
behaviors. Eighteen (female n=13,  male n=5) stated unprotected sex is associated with HPV. 
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One student offered, “If you don't have the vaccine and have unprotected sex with a lot of 
people.” Fifty-three (female n=39, male n=14) stated number of partners and engaging in sexual 
activity. “If I go sleeping around with multiple people and one of them carry the virus but I don’t 
do that so my chance of getting it is low.”  
Students identified protective factors related to vaccine status or relationship status. 
Students specifically emphasized either abstinence or monogamy as important.  Twenty-seven 
(female n=19, male n=8) provided answers related to celibacy, not engaging in any sexual 
activity, or being a virgin lowered their potential HPV risk. One student illustrated the latter 
response by saying: 
“I am not sexually active, nor have been, nor will be until I get/ if I get married. I will 
only have sex with that one man... therefore there is a slim to none chance of me ever 
getting it.” 
Fourteen students (female n=11, male n=3) related low risk of HPV to being monogamous and 
faithful to their partner. Most of these students identified as being in a committed relationship 
with only one partner as illustrated by this student response, “I currently would not consider 
myself at high risk for getting HPV because I am in a long-term, monogamous relationship with 
a woman.”  
A small group 15 (female n=12, male n=3) identified the HPV vaccine as a protective 
factor. It was anticipated that students would associate their own vaccine status with their risk, or 
mention the vaccine as lowering one’s risk.  
There were 17 erroneous answers that were grouped together by responses that implied 
lack of HPV knowledge and risk misperceptions about contracting HPV. One student said, “I 
know condoms don’t prevent it” while another said,  “I work in a higher risk environment 
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delivering to people, so I could be at a higher risk to get it.” Among these ‘unexpected’ 
responses were smoking and family genetics: “smoking, taking birth control, sexual history, etc.” 
and “I'm assuming that as with a lot of sicknesses genetics could influence it”.  An additional six 
students appear to have misunderstood the question prompt. Curiously, ten of the students that 
fell in the category of erroneous responses reported they had been fully vaccinated or were 
partially vaccinated in a previous question. 
A group of 22 students (female n=15, male n=7) stated they did not know what 
influences their chance of getting HPV. One student commented, “I am not sure as I have never 
been told.” It was noted that18 of these students had not received a provider recommendation for 
the vaccine. Furthermore, six students responded “N/A” with three  of those students having not 
received the vaccine. A student said, “the amount of sex you have? I honestly have no clue about 
















  This study contributed to the limited literature regarding college student HPV knowledge 
and vaccine decision making. Research questions included (a) What were students’ vaccine 
status? (b) What were students’ HPV knowledge scores? (c) What were students’ perceived risk 
of contracting HPV? A critical exploratory component of this study was to understand how 
health care providers influence student HPV vaccine decision making by asking students about 
their conversations with their health care providers and what information providers are sharing. 
This study used a self-administered, web-based quantitative survey with qualitative exploratory 
questions to arrive at the study aims. 
In this study, 58.8% (n=142) of students overall had received a vaccine recommendation, 
and 57.2% (n=140) had been fully or partially vaccinated. These rates align with the literature 
that states HPV immunization rates in college students are significantly below the US 
Department of Health and Human Service’s Healthy People 2020 goals of 80% being fully 
covered (Kellogg et al., 2019). The CDC (2020) continues to report higher uptake and earlier 
initiation of the series for females than males. The CDC (2020) also reports higher percentages 
of women who have received one or more dose (53.6%) compared to men (27%). The literature 
holds a physician recommendation is the strongest predictor of HPV vaccine receipt (Fazekas, 
Brewer, & Smith, 2008; Kasting, et al., 2016; Kim and Nan 2016; MacArthur, 2017; Rosenthal 
et al., 2011). In this study, 58.8% (n=142) of students overall had received a vaccine
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recommendation, and 57.2% (n=140) had been fully or partially vaccinated. Females (n=105; 
63%) were more likely to report they had received a provider recommendation for vaccine than 
males (n=37; 48.7%) The specific narratives of vaccinated students showed the provider attitude 
and confidence directed towards the student (or to their parents when they were younger), was a 
powerful influence for getting the vaccine. One student recalled, the provider “… influenced my 
decision because he is an expert regarding health.”  
In contrast, there was also a considerable group of students who reported they were 
unsure of their vaccine status (n=79; 32.2%). There was no difference by gender in these results. 
Both female and male students reported they were uncertain if they had been vaccinated, and 
many said they have never received a provider recommendation for the vaccine. Half of the 
males (n=39; 51.3%) had not received the recommendation (e.g., “I didn't get one because I can't 
remember one ever being recommended”).  
 These categories of vaccine status will be presented in the discussion below, as they 
shape the student narratives in these data. It appears the student stories are divided among those 
who have the vaccine and those who are unsure of their vaccine status. The existing literature is 
supported in this study’s findings which present similar nuances that originally drove this study. 
The following discussion includes themes of the findings: (a) HPV knowledge is limited, and 
misinformation exists, (b) students’ perception of risk may be underestimated; therefore, students 
seem to think the vaccine does not apply to them and (c) the health care provider should be a 





HPV Knowledge is Limited 
This study demonstrated college students do not have thorough knowledge of HPV; 
instead, students hold many misconceptions and have limited knowledge about the nature of the 
disease. The literature has been consistent since the introduction of the HPV vaccine in that 
knowledge scores vary by gender and across specific questions related to disease and vaccine 
(Fontenot et al., 2014; Gao, Okoror, and Hyner, 2016; Jozkowskia and Geshnizjani, 2016; 
Staggers, Mann, and Maki, 2012). Kellogg et al. (2019) found similar variations in knowledge: 
there is a lack of more detailed understanding of the virus and its related health conditions, lack 
of awareness among college students regarding the prevalence of HPV, and their risk of 
becoming infected with the virus. 
The knowledge scores for this study were quite low. Females had slightly higher HPV 
knowledge scores, but there were no significant differences by gender. Despite 57.4% of students 
being vaccinated, overall knowledge scores had a mean of 12.16 (of a possible 25). This aligns 
with some studies in the literature where students’ vaccination status was associated with lower 
HPV knowledge (Schmotzer et al., 2013). In the current study, students who were not vaccinated 
had slightly higher scores than those who were fully/partially vaccinated. Ratansiripong (2015) 
found knowledge was not directly associated with the outcomes of vaccination status and 
intention. In the current study, students that had slightly higher knowledge may have made an 
informed decision to not be vaccinated. Existing literature is contradictory, some studies show 
that HPV knowledge and awareness correlate with having received the vaccine, others have 
shown that knowledge was not correlated with HPV vaccination status (Kellogg et al., 2019). 
Kellogg et al. (2019) also noted self-perceived or actual level of HPV knowledge did not 
influence the self-reported immunization status.  
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Students who were unsure of their vaccine status had the lowest knowledge scores. 
Kellogg et al. (2019) found one-quarter (23.6%) of the college students in their study did not 
know their immunization status, demonstrating a lack of communication between the provider 
and these patients. This concern exists in the current study. Students in the unsure category 
scored significantly lower and were unable to identify risk factors related to contracting HPV. 
Health care provider interactions with college students unaware of their vaccination status should 
provide education and counseling on risk factors related to the disease. Some students may 
believe the vaccine is only administered to younger individuals (Kellogg et al., 2019), health care 
providers should explain to college age students they can indeed benefit from the vaccine as this 
age group is viewed as the ‘catch up’ opportunity (Boersma & Black, 2020). 
Boersma and Black (2020) report in 2018, 18.5% of adults who had ever received one or 
more doses of HPV vaccine received their first dose of HPV vaccine at age 12 or under, 25.6% at 
age 13−14, 34.5% at age 15−17, and 21.4% at age 18−26. Given young age of first dose, it is 
likely that many college students did not directly have educational messaging from their health 
care provider. Students vaccinated in their youth likely did not receive HPV education, as 
provider communication was geared toward the parent (e.g., I was given the vaccination when I 
was a child, so my parents made the decision. I was not told anything about it that I remember”; 
“I don’t remember them telling ME anything, they spoke to my mom and got HER permission”; 
“It was all done prior to me turning 18”). Another position is that students who were vaccinated 
may not have received or remembered HPV related information. In this situation, students may 
be aware of HPV, but lack specific knowledge about it. Several students commented to this last 
point in the exploratory questions as they were told to get the vaccine but were not given details 
related to HPV (e.g., “I still don’t know what HPV is” and “a vaccine will reduce my chance of 
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getting it, although I was never really told exactly what it was”). When asked what information 
providers had communicated to the students, 41.7% of students stated they received no 
information from their provider or do not remember (e.g., Nothing. I’ve never had a health care 
provider tell me about HPV.” 
Each of the instrument’s knowledge statements were examined closer to identify where 
the gaps in knowledge lie (See Table 8: Knowledge of HPV and HPV Vaccines). Students knew 
the least about HPV screening methods and methods of HPV treatment. Consistently, student 
scores related to the five screening and testing statements were less than 37%, four of those were 
below 24.3%. Of interest, there were no student narratives recalling messages of HPV testing or 
HPV treatment from their providers. Karymova, Harrison, and Pascal (2019) similarly found 
students knew the least about HPV screening and testing. College students stand to benefit 
comprehensive HPV education.  The American College of Obstetricians and Gynecologists 
(ACOG) (2016) recommends comprehensive sexuality education should begin in early childhood 
and continue through a person’s lifespan. It is quite likely that screening and testing was not 
discussed with students that were vaccinated when younger. Further, it may be that students did 
not have sexual health education during adolescence, thus explaining low knowledge in several 
content areas in this study.  
Of concern, only 25.4% of students correctly answered ‘most sexually active people will 
get HPV at some point in their lives’. College students have not correctly understood this risk in 
other studies, where they underestimate risk and do not get this knowledge question correct 
(Karymova, Harrison, and Pascal, 2019).  This is surprising given that 76.1% of participants 
correctly answered that HPV is not ‘very rare’.  For these two knowledge statements, students 
did not appear to see the linkage between how common HPV is and personal susceptibility. This 
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phenomenon has been cited in the literature, in a study of over 4,000 students, only 18% of 
respondents believed that they were at risk of acquiring a genital HPV infection in their lifetime 
(Patel et al., 2013).  Previous research previous research with college populations has found a 
large portion of women who believe themselves to be “not at risk” for HPV actually test positive 
(Karymova, Harrison, and Pascal, 2019).  This is concerning because college students comprise 
the age groups for females at highest risk for HPV, specifically with 20 to 24-year-old females 
having the highest prevalence of genital HPV (Thompson et al, 2016).  Recall, most people with 
HPV do not know they are infected (CDC, 2014). According to the Health Belief Model (HBM) 
low perceived risk for HPV is likely to decrease an individual’s willingness to engage in 
vaccination (Karymova, Harrison, and Pascal, 2019).  College health centers could play a key 
role in raising awareness of how common the disease, and promotion of behaviors to lessen risk.  
Students had the greatest understanding of the relationship between HPV and sexual 
behaviors; but this may be limited to the following specific knowledge statements. 84.4% 
correctly answered that having many sexual partners increases the risk, and 81.1% knew HPV 
can be passed during sexual intercourse. 72.8% also knew that condoms reduce the risk of 
getting HPV. This aligns well with the answers provided in the student narratives. More than half 
related greater risk of contracting HPV to number of partners, having unprotected sex, and being 
sexually active (e.g., “Unprotected sex, sex with multiple partners” and “Sleeping around with a 
lot of people, especially people you don’t know that well”). Some students spoke about their own 
behaviors and perceived reduced risk: “If I go sleeping around with multiple people and one of 
them carry the virus but I don’t do that so my chance of getting it is low.” 
When asked what information providers conveyed about HPV or the vaccine, only six 
students specifically described their providers had communicated about transmission through 
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sexual activity. Just over half (54.4%) knew that ‘HPV can be passed on by genital skin-to-skin 
contact’, a finding similar to that of Kellogg et al. (2019). This is quite interesting considering 
many students correctly answered other questions relating HPV to sexual behaviors. The 
implications are that students may have different definitions of sexual behaviors and that HPV 
information comes from multiple sources. Sexual health education historically has been limited 
to abstinence only messaging with medically accurate messaging varying by definition from state 
to state and within school districts (ACOG 2016). It is plausible that many students in this study 
received limited or no sexual health education from a health care provider as an adolescent or 
their parent. ACOG (2016) reports one third to one half of female adolescents 15 to 19 years old 
have never discussed sexual related topics such as STIs with their parents. The lack of sexual 
health conversations would explain weak scores on specific knowledge questions and the 
contradictions in knowledge that students hold. 
This study aligns with the common finding in the HPV literature that college students 
hold misconceptions about HPV and the vaccine (Albright and Allen, 2018; Schmotzer et al., 
2013, Wolwa et al., 2013). The misconceptions were shown by the low percent of students able 
to identify the false statements within the knowledge scale, and some students’ narrative answers 
the open-ended questions. Students were presented the statement ‘HPV can cause HIV/Aids’; 
only 21.2% correctly identified this statement as false. Similarly, only 14% knew this statement 
was false: ‘when you have an HPV test, you get the results the same day’. 
Seventeen students provided erroneous narratives when asked about risk factors related to 
getting HPV. It is interesting that ten of these students had been fully or partially vaccinated. One 
student said,  “I'm not sure. I know condoms cannot prevent the spread, so I guess limiting the 
number of sexual partners you have.” These misconceptions included use of birth control (e.g., 
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“long term use of oral contraceptive (birth control))”, genetics, and smoking. Several students 
indicated heredity and genetics played a role, “I'm assuming that as with a lot of sicknesses 
genetics could influence it.” A small assortment of other misconceptions presented: one student 
stated, “I know condoms won’t prevent it.” A few students indicated their work environment and 
exposure to other people at work would impact risk (e.g., “I work in a higher risk environment 
delivering to people, so I could be at a higher risk to get it”).   
Some students mentioned their health care provider discussed the vaccine as an avenue to 
prevent cervical cancer or cancers. However, this seems specific only for those who had received 
a provider recommendation for the vaccine. Overall, students had varying knowledge related to 
the purpose or nature of the HPV vaccines with many misunderstandings. Of the knowledge 
items presented, very few students (24.7%) knew ‘HPV vaccines are most effective if given to 
people who have never had sex’ or ‘HPV vaccines offer protection against most cervical 
cancers’. Another knowledge item had surprising results; 43.6% thought the HPV vaccines offer 
protection against all sexually transmitted infections.  
The body of the literature is confounding, where knowledge is assumed to be a driver of 
vaccine acceptance, many studies indicate knowledge alone is not sufficient to increase uptake 
(Bennet et al., 2015; Ratansiripong, 2015; Patel et al., 2012). For example, Richman et al. 
provided educational interventions to increase knowledge, although knowledge was raised, it did 
not result in vaccine uptake (2016). Except for the linkage between HPV and sexual behaviors, 
low HPV knowledge scores and misperceptions about the vaccine seem common among all 
students. This an important consideration moving forward, as student narratives related to sexual 
activities or the lack thereof, were a salient theme among students discussing their personal 
perceptions of risk and overall risk factors. 
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College and university campuses can take lead to initiate discussions about HPV and 
vaccination (Karymova, Harrison, and Pascal, 2019), from the severity and commonness of the 
disease, to preventative measures. Sexual health messaging and HPV education can open 
conversations between students and their health care provider to determine their vaccine status, 
and whether testing and screening would be beneficial.  Ultimately, health care providers should 
not assume based on vaccination status the extent of a student’s HPV knowledge. Instead, they 
should tailor messaging to each student to close gaps in knowledge and resolve misconceptions 
that exist. 
College Students May Underestimate Their Risk of HPV 
         There were differences in level of perceived risk of contracting HPV by vaccination 
status. Interestingly, both fully/partially vaccinated and unvaccinated students largely reported 
their perceived risk ‘much below average’ and ‘below average’. Students unsure of their vaccine 
status reported their risk as ‘average’ most often. Furthermore, students were specifically asked 
in an open-ended question ‘What influences your risk of getting HPV?’ The student narratives 
provided insight to their perceptions of risk. In the literature, perceived severity of HPV infection 
or cervical cancer has not emerged as a correlate of vaccine acceptability in women (Gerend & 
Barely, 2009). Students in this study seem to judge their risk perception not on perceived 
seriousness or severity of HPV as suggested by the Health Belief Model, but on their personal 
behaviors, which is consistent within the literature (Hopfer & Clippard, 2017; Thompson et al., 
2017).   
Thompson et al. (2017) found unvaccinated single women perceived themselves at zero 
risk for HPV, which was attributed to lack of sexual activity. In the current study, many students 
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reported perceptions of low risk of getting HPV due to not being sexually active, similar to other 
studies (Bednarczyk et al., 2011, Burke et al., 2010; Thompson et al., 2017). Students in this 
study also based their risk perception on their relationship status, which is also documented in 
the literature (Hopfer & Clippard, 2017; Thompson et al., 2017). Thompson et al. (2017) believe 
that perceptions of risk may not align with vaccine uptake. Studies have shown students possess 
a “…dismissiveness about susceptibility.” (Pitts & Stanley, 2017).  Fontenot et al. (2014) found 
male participants did not believe they were at risk for contracting HPV and therefore did not 
perceive the need to obtain the vaccine. Students appear to be judging their risk based on current 
behaviors, rather than thinking of the benefit of the vaccine in the future (as seen in Thompson, 
et al., 2017). 
In this current study, a group of students believe that being monogamous, being a virgin, 
or not currently being sexually active is protective from HPV (e.g., “I am not sexually active and 
my chances as of now are 0%”). None of these students overtly indicated they were intentionally 
delaying the vaccine, but it appears they believe the vaccine is not necessary for them. 
Specifically, there seems to be an underlying mindset the vaccine does not apply to them because 
they are not having sex (e.g., “I am a virgin and plan on only having one sexual partner” and 
“Well, considering that HPV is an STD, not having sex increased my chances of not getting it. I 
am waiting for marriage, so I will not have multiple partners). This belief system is seen in the 
literature where students not sexually active were not worried about getting HPV (Burke et al., 
2010). These students do not seem to recognize they would receive the greatest benefit from the 
vaccine if vaccinated prior to starting any sexual activity. Recall that most students did not know 
the vaccine is most effective when given to those that have never had sexual activity. Only 
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fourteen students overtly stated that having the vaccine was protective of HPV (e.g., “I have the 
vaccine so I should be safe compared to those who don't have it”).  
  The existing literature holds some students are waiting until they are sexually active to 
get the vaccine; they believe that if they are not sexually active, the vaccine is unnecessary 
(Dillard and Spear, 2010). This may be the case for students in the current study. This is 
concerning from a primary prevention standpoint. Most people get HPV infections shortly after 
becoming sexually active for the first time (NIH, 2015), and it is possible to become infected 
with more than one type of HPV (CDC, 2015). The literature also indicates students lack 
perceived susceptibility and do not understand the severity of health consequences associated 
with HPV (Staggers, Mann, & Maki, 2012). Of note, not even half of the students in this current 
study knew that ‘there are many types of HPV’.  The HBM holds that when HPV/HPV-related 
diseases are perceived as serious conditions, this increases the likelihood that an individual 
intends to get the vaccine (MacArthur 2017). However, in this current study, students’ low 
knowledge scores related to HPV causing genital warts and types of cancer indicates students do 
not understand HPV as a serious condition.  
The rationale for delaying vaccination until initiation of sexual activity may not provide 
the protection necessary.  Gardasil9, the current vaccine, requires several doses for efficacy. For 
many, the series will span six months from initiation to completion (Merck, 2020). It may be that 
students are not aware of the dosing schedule; or rather, there is an erroneous outlook that when 
they initiate sexual behaviors, they can get the HPV vaccine and secure immediate protection.  
         The student narratives in this study show a group of students were unable to identify 
HPV risk factors. Frank statements include: “the fact that I don't know what it is and don't have 
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a doctor”; “the amount of sex you have? I honestly have no clue about HPV or what causes it”; 
and “I am not sure that's why I think I am just average; I have never heard that I am at high risk 
for it or low risk for it.” Even more common to this group of students’ responses was the simple 
statement “I do not know.” 
Health Care Provider Communication Needed 
         An important study aim of this study was to gather student perspectives on how health 
care providers communicate HPV and HPV vaccine messages to college students. The HBM 
construct of ‘cue to action’ would suggest the provider recommendation is the best predictor for 
improvement of vaccination uptake. Given the opportunity to recall conversations, students 
provided a host of narrative responses. The CDC and the President's Cancer Panel have 
identified improving healthcare providers' communication as a key strategy for increasing HPV 
vaccine uptake (Gilkey et al., 2015).  
There appears a triangulation within the study findings that a group of students have not 
received a provider recommendation for the vaccine, they have low HPV knowledge, and they 
cannot identify HPV risk factors. According to the HBM, a cue to action in the form of a 
provider recommendation has significant implications that influence vaccine uptake. In the 
current study, often the provider did not serve in this role. This belief was strengthened by 
examining the student narratives closer: the same students that stated they were not influenced by 
their provider had not received a vaccine recommendation. Similarly, students that did not know 
what influences their risk had not received a recommendation.  
About 45.7% of the students believed the health care provider was not an informational 
source nor an influence on the vaccine decision (39%). One student said, “I cannot recall a 
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conversation with my health care provider about HPV.” Narratives came from students in each 
group (those that had and had not received recommendation to vaccinate; and within each 
vaccination status group) that they had received little, or no information related to the nature of 
HPV. These students said the provider was not an influence (e.g., “The healthcare provider did 
not influence my decision about the HPV vaccination” and “They haven’t as I am unaware of 
what it is”). While some were influenced by the provider's attitude towards the vaccine, many 
reported not receiving HPV information at the same time (e.g., “ I still don’t even know what it 
is”). This finding is consistent with Hopfer and Clippard’s (2017) study where many women 
based their decisions on provider attitudes and health care provider messages, while having only 
superficial HPV knowledge.  
         An additional group of students stated the provider was not a direct information source or 
influence on them because provider educational messaging was relayed only to the parent. It is 
evident in this study that knowledge and educational messaging were not transferred from the 
provider, nor the parent, to the adolescent. Students often identified their parents as the key HPV 
vaccine decision makers when they were younger. One student stated, ‘they didn’t tell ME 
anything, they just talked to my mom’. Whether the vaccine is received or not, the young person 
may leave the provider’s office without HPV specific knowledge related to the nature of the 
disease, the outcomes, routes of transmission, etc. For males and females, the mother was often 
specified as the HPV decision maker whose approval, or lack thereof, was the key factor of 
whether they were vaccinated or not. A few female students in this current study briefly 




Much existing literature focuses on the predominance of provider communications to 
parents of children and adolescents (Daley, Liddon, Kempe, et al. 2006, Dillard & Spear, 2010; 
Dorrell, Yankey, & Strasser, 2011; McRee, Gilkey, and Dempsey 2014, Jones & Cook, 2008). It 
was not a goal of this study to understand to what extent college students had family 
communications about HPV or included their parents in HPV vaccine decision making. This may 
be a valuable avenue for future investigation because the role of the parent in health care 
decision making likely extends into young adulthood when students are in college. There is an 
assumption that college students are autonomous decision makers; however, parental influence 
may continue related to the HPV vaccine. Omitting children from the vaccine conversation is 
understandable as it may be objectionable to discuss topics of sexuality, cancer prevention, etc. 
with children at the lower end of the recommended age groups (9-15 years old). However, a gap 
in HPV knowledge and risk perception will persist as the child enters young adulthood and 
college as illustrated by the 32% of students who were unsure of their vaccine status. 
Limitations 
While this study contributed to the body of literature related to college student knowledge 
about HPV and provider conversations with college students about HPV, the study sample was 
relatively small (N=254) and comprised primarily of white/Caucasian female students (n=167; 
68.%) from suburban communities (n=134; 57.7%). While this study purposefully oversampled 
males with the initial email distribution in efforts to collect a higher percent of male respondents, 
the male response rate was sluggish. The current study had 57 (23.3%) of the respondents 
identify within a minority race/ethnic group; but no individual race/ethnic groups were strongly 
represented. Unfortunately, this study did not contribute more to minority college student 
perspectives on HPV. The existing literature is lacking minority perspectives related to many 
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HPV topics and points towards future research in such areas as uptake rates, decision making, 
information sources, knowledge, etc. 
Conclusions 
         Even though 18–24-year-old college students have been vaccine eligible since the HPV 
vaccines were initially manufactured; there should be continued investigation as to why uptake 
remains low, why college student knowledge surrounding HPV is sparse, and why health care 
providers are not recommending the vaccine more often. While the role of the health care 
provider is widely known to increase uptake, Bennett et al. (2015) suggest strategies should not 
be limited to only provider conversations. On-campus strategies to assist in increasing college-
aged vaccination rates are recommended; these involve providing college students with HPV 
education and offering the HPV vaccine during orientations or clinics (McCutcheron & Schaar 
2017). ACOG (2016) also supports continuing sexuality education through the lifespan. For 
college students, this education can be facilitated through health education professionals and peer 
education efforts on campus. Tailored online educational interventions may also serve to reach 
students that are not having provider contacts (Bennett et al., 2015).  
Medically accurate sexual health education is needed for all students. Providers 
interacting with college age students should be alert that HPV knowledge is poor regardless of 
vaccine status. The results of this study indicate it is necessary for the health care provider to re-
visit the HPV conversation with college students when given opportunity. Students hold 
misconceptions about testing, transmission, and the benefits of the vaccine. The Health Belief 
Model constructs may not apply to college student vaccine decision making, given students’ low 
knowledge about the seriousness and severity of the disease in this study and that many do not 
know what makes them at risk of contracting HPV.  
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Students do not understand the best time to be vaccinated is prior to having any sexual 
activity. Instead, there is a belief that if one is not sexually active, one can wait to vaccinate. For 
students vaccinated when they were younger, a return to the HPV conversation would clarify 
benefits of the vaccine and resolve misunderstandings. Additionally, health care providers should 
be the cue to action, making the vaccine recommendation to both the unvaccinated student and to 
those students who believe the vaccine does not apply to them, by explaining how they are the 
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HPV Knowledge Instrument  
Consent Information 
Q1 As of today's date are you between 18 and 24 years old? 
o Yes   
o No   
Skip To: End of Survey If As of today's date are you between 18 and 24 years old? = No 




Q3 What is your race/ethnicity? 
o American Indian or Alaska Native    
o Asian    
o Black or African American   
o Hispanic, Latino, or Spanish   
o Native Hawaiian or Pacific Islander   
o White   
o Bi-Racial   
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o Graduate( or higher) 
o Concurrent, still in high school taking college classes 
Q5 How would you describe the area where you spent most of your adolescence (10-19)? 
o Rural (small towns or cities isolated from larger areas or farming communities)   
o Suburban (community near a bigger city, often part of a metropolitan region)   
o Urban (big city – i.e., Austin, Little Rock, Memphis, Tulsa)    
o Megalopolis (extra-large city with an especially diverse population – i.e., New  
York City, Chicago, Los Angeles)   
 
Q6 What is your HPV (Human Papillomavirus) Vaccine Status? 
o Partially HPV vaccinated (some doses, but not all)   
o Fully HPV vaccinated (all doses received)  
o Not at all HPV vaccinated   
o Unsure   
 
Q7 Has a health care provider (doctor, nurse) ever recommended an HPV vaccine to you? 
o Yes   
o No   
This study wants to understand what health care providers say to college students about HPV (Human 
Papillomavirus). Please think back to conversations you have had with your doctor or nurse. 
Q8 What information has a health care provider given you about HPV? 
Q9 How did the health care provider influence your decision about HPV vaccination? 












Compared to other people my 
age, I think that my chance of 
getting HPV is…  




Q 12 What would influence your chance of getting HPV, or not getting HPV? 
Q13  Select if the statement is True, False, or I Don't Know. 
        If you don't know the answer, please select 'I Don't Know' instead of guessing. 
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 True  False  Don't Know  
HPV can cause cervical 
cancer (1)  
o  o  o  
A person could have HPV 
for many years without 
knowing it (2)  
o  o  o  
Having many sexual 
partners increases the risk 
of getting HPV (3)  
o  o  o  
HPV is very rare (4)  o  o  o  
HPV can be passed on 
during sexual intercourse 
(5)  
o  o  o  
HPV always has visible 
signs or symptoms (6)  
o  o  o  
Using condoms reduces 
the risk of getting HPV 
(7)  
o  o  o  
HPV can cause HIV/Aids 
(8)  
o  o  o  
HPV can be passed on by 
genital skin-to-skin 
contact (9)  
o  o  o  
Men cannot get HPV (10)  o  o  o  
Having sex at an early age 
increases the risk of 
getting HPV (11)  
o  o  o  
There are many types of 
HPV (12)  
o  o  o  
HPV can cause genital 
warts (13)  
o  o  o  
HPV can be cured with 
antibiotics (14)  
o  o  o  
Most sexually active 
people will get HPV at 
some point in their lives 
(15)  
o  o  o  
HPV usually doesn’t need 
any treatment (16)  
o  o  o  
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Girls who have had an 
HPV vaccine do not need 
a Pap test when they are 
older (17)  
o  o  o  
One of the HPV vaccines 
offers protection against 
genital warts (18)  
o  o  o  
HPV vaccines offer 
protection against all 
sexually transmitted 
infections (19)  
o  o  o  
Someone who has an 
HPV vaccine cannot 
develop cervical cancer 
(20)  
o  o  o  
HPV vaccines offer 
protection against most 
cervical cancers (21)  
o  o  o  
HPV vaccines are most 
effective if given to 
people who have never 
had sex (22)  
o  o  o  
If an HPV test shows that 
a woman does not have 
HPV her risk of cervical 
cancer is low (23)  
o  o  o  
HPV testing is used to 
indicate if the HPV 
vaccine is needed (24)  
o  o  o  
When you have an HPV 
test, you get the results 
the same day (25)  
o  o  o  
HPV can sometimes 
spontaneously clear 
without treatment (26)  
o  o  o  
Q14 Do you want to be entered into a lottery drawing for a chance to win an Amazon gift card? Prizes are 
1:$50, 2:$25, and 10:$10 gift cards. Your answers to the survey are still anonymous.  
o Yes   
o No   
Display This Question: If Do you want to be entered into a lottery drawing for a chance to win an 
Amazon gift card? Prizes... = Yes No 
Q15 If you win one of the Amazon gift cards, you will be contacted by email. Your answers to the survey 
are still anonymous, your answers are not linked to your email. Please provide the best email to reach you 
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Table 1    
Characteristics of Participants 
Demographics  % Responders (n) 
Gender   
      Female 68.2 (167) 
      Male 31.4 (77) 
 Transgender 1 (.4) 
Race/ethnicity   
       White 76.7 (188) 
      American Indian 6.1 (15) 
      Asian 4.9 (12 ) 
      Black or African American 2.4 (6) 
      Hispanic, Latino, or Spanish 6.9 (17) 
      Native Hawaiian/Pacific Islander .4 (1) 
 Biracial 2.4 (6) 
College classification   
 Freshman 31.8 (78) 
 Sophomore 20.4 (50) 
 Junior 26.9 (66) 
 Senior 19.6 (48) 




 Suburban 57.7 (134) 
 Rural 28.2 (69) 
 Urban 15.9 (39) 
 Megopolis 1.2 (3) 
Received a provider 
Recommendation 
  
 Yes 58.8 (142) 
 No 41.2 (100) 
HPV vaccine status   
 Fully vaccinated 52.7 (129) 
 Partial/initiated 4.5 (11) 
 Not at all vaccinated 10.6 (26) 
 Unsure 32.2 (79) 
   
Note: N=245. Participants were between 18 and 24 years old. N=243 question: Did a health care provider 







Chi-Square Results by Gender: Vaccine Status, Provider Recommendation, and Perceived Risk 






 n                      % n                       %  
Vaccine Status 
    Fully/Partially Vaccinated 
    Not Vaccinated 
    Unsure 
 
 
41               53.2% 
9                 3.7% 
27               35.1% 
 
  99               59.3% 
17                0.2% 






    Yes 
    No 
 
37               48.7% 
39               51.3% 
 
 
105              63.3% 
  61                36.7% 
4.56* 
Perceived risk 
   Much Below Average 
   Below Average    
   Average 
 
 
19              35.8% 
14               32.6% 
20               37.7% 
 
 58                43.9% 
 43                30.8% 
 51                27.6% 
.146 



































 n            % n            % n             %  
Perceived risk  
   Much Below Average 
 
 
  50         48.1% 
 
 
10     43.5% 
 




    Below Average   
 
 33         31.7% 7        30.4% 17        28.8%  
    Average 
 
 21         20.2% 
 
6      26.1% 25         42.4% 
 
 


























 M                            SD F ratio df 
Vaccine Status 
    Fully/Part. Vaccinated 
    Not Vaccinated 
    Unsure 
 
 
  12.9                       5.90 
13.7                       5.93 
  10.1                       6.30 
4.495* 2,177 
Hometown 
    Rural 
    Suburban 
    Urban 
 
 
11.5                        3.23 
12.1                        6.45 
13.4                        4.93 
.973 2,177 


















What Information Has a Health Care Provider Given You About HPV? 
Salient Themes    Example Quote          Frequency, n (%) 
 
I don’t know    I've never been told what HPV is.                         63 (41.7) 
Prevention focused                     This vaccine prevents one of the most                    49 (32.4) 
          common forms of STIs and is important to get.  
Recommendation, with information    They told me to look into it before I            22 (14.6) 
  headed to college. And said it would be good to get.  
  They then explained what it was.  
Talked to parent                                  My mom was who they talked to at the time            11 (7.3) 
              of the vaccine so I have no idea what it's about. 
HPV=STI     That it will help prevent me from                              6 (4.0) 
 getting a sexually transmitted disease.    
Recommendation, no information      Nothing. Only that I need it.                                       6 (4.0) 
       Still don’t know what HPV is. 
Print materials received   When going in for a well woman's exam                  5 (3.3) 
  it was mentioned to me. I also got a pamphlet 










How Did the Health Care Provider Influence Your HPV Vaccine Decision? 
Salient Themes    Example Quote          Frequency, n (%) 
 
Provider approval         A big influence, would never have known about the        53 (37.06) 
       risks otherwise.  
Not applicable*                            30 (21.0)  
No influence           They have not because I do not recall them                     26 (18.2) 
        ever telling me to get the vaccination.  
Parent made decision          My mom took me to get it as a teenager,           21 (14.7) 
        never knew much about it. 
Risk, fear, guilt message      They tried scaring me into thinking I would           11 (7.7) 
          get cancer if I did not get this vaccine. 
















What Influences Your Risk of HPV Infection? 
Salient Themes    Example Quote          Frequency, n (%) 
 
Number of sexual partners,     How sexually active you are.         53 (34.0)  
    Sexual activity 
Celibacy, no sexual activity  I am not sexually active, nor have I ever been.               26 (16.7) 
Faithfulness, monogamy       I am only sexually active with one person,        23 (14.7)      
and he is only sexually active with me. 
I don’t know              I am not sure as I have never been told.                   22 (16.7) 
Vaccinated or not     I have the vaccine so I should be safe        18 (11.4) 
 compared to those who don't have it 
Unprotected sex               18 (11.5) 
‘Unexpected’ answers           Smoking, taking birth control, sexual history, etc.             17 (11.0) 
              Genetics 













Table 8:  
Knowledge of HPV and HPV Vaccines: 
 
Knowledge items          % correct(n) 
___________________________________________________________________________ 
Having many sexual partners increases the risk of getting HPV   84.4 % (180) 
HPV can be passed on during sexual intercourse     81.1 % (180) 
A person could have HPV for many years without knowing it   76.1% (180) 
HPV is very rare         76.1 % (180) 
Men cannot get HPV         73.9 % (180) 
Using condoms reduces the risk of getting HPV     72.8 % (180) 
HPV always has visible signs or symptoms      68.3 % (180) 
Girls who have had an HPV vaccine do not need a Pap test when they are older 65.2 % (178) 
Someone who has an HPV vaccine cannot develop cervical cancer   60.1 % (178) 
HPV can cause cervical cancer       58.9% (180) 
HPV vaccines offer protection against all sexually transmitted infections  56.4 % (179) 
HPV can be passed on by genital skin-to-skin contact    54.4 % (180) 
HPV can cause genital warts        53.1 % (179) 
There are many types of HPV       41.9 % (179) 
HPV testing is used to indicate if the HPV vaccine is needed   39.3 % (178) 
Having sex at an early age increases the risk of getting HPV   38.8 % (178) 
HPV can be cured with antibiotics       37.6 % (178) 
Most sexually active people will get HPV at some point in their lives  25.4 % (177) 
HPV vaccines offer protection against most cervical cancers   24.7 % (178) 
HPV vaccines are most effective if given to people who have never had sex 24.7 % (178) 
HPV can sometimes spontaneously clear without treatment    24.3 % (177) 
One of the HPV vaccines offers protection against genital warts   22.7 % (176) 
HPV can cause HIV/Aids        21.2 % (180) 
If HPV test shows…woman does not have HPV, her risk of cervical cancer is low 15.2 % (178) 
When you have an HPV test, you get the results the same day   14.0 % (178) 
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